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Small-angle x-ray scattering (SAXS) imaging has been proposed as a tech-
nique to characterize and selectively image structures based on electron density
structure which allows for discriminating materials based on their scatter cross sec-
tions. This dissertation explores the feasibility of SAXS imaging for the detection
of Alzheimer’s disease (AD) amyloid plaques. The inherent scatter cross sections
of amyloid plaque serve as biomarkers in vivo without the need of injected molec-
ular tags. SAXS imaging can also assist in a better understanding of how these
biomarkers play a role in Alzheimers disease which in turn can lead to the develop-
ment of more effective disease-modifying therapies. I implement simulations of x-ray
transport using Monte Carlo methods for SAXS imaging enabling accurate calcu-
lation of radiation dose and image quality in SAXS-computed tomography (CT).
I describe SAXS imaging phantoms with tissue-mimicking material and embedded
scatter targets as a way of demonstrating the characteristics of SAXS imaging. I
also performed a comprehensive study of scattering cross sections of brain tissue
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generalized cross sections of gray matter, white matter, and corpus callosum ob-
tained and registered by planar SAXS imaging. Finally, I demonstrate the ability of
SAXS imaging to locate an amyloid fibril pellet within a brain section. This work
contributes to novel application of SAXS imaging for Alzheimer’s disease detection
and studies its feasibility as an imaging tool for AD biomarkers.
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The purpose of this work is to study the feasibility of small-angle x-ray scat-
tering (SAXS) to detect Alzheimer’s disease biomarkers in vivo. We study SAXS
because it is tailored to characterizing molecular structure and aggregates and could
be applied as a medical imaging tool for detection of Alzheimer’s disease. This chap-5
ter provides a description of Alzheimer’s disease, the general theory of SAXS, and
the scope of the dissertation.
1.1 Overview of Alzheimer’s disease
Alzheimer’s disease (AD) is an insidious neurodegenerative disorder character-
ized by impaired memory, reduced cognitive skills, and diminished ability to perform10
everyday tasks. It is the most common cause of dementia, accounting for 60-80% of
cases. Like many other neurodegenerative disorders, there is still no cure, nor ways
of slowing or reversing the disease progression. [40] As of 2017, the National Insti-
tute on Aging estimates that as many as 5.5 million Americans suffer from AD. [3]
Recent discoveries reveal that biomolecular changes associated with AD occur 2015
or more years before dementia symptoms appear. Early detection of these changes
may be pivotal to developing therapies based on molecular behavior to preventing,
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slowing, and ultimately stopping AD. [45,71,84,89]
Two hallmarks of AD onset is the accumulation of β amyloid (Aβ) plaques
and neurofibrillary tau tangles in the brain. Aβ plaques originate from an amy- 20
loid precursor protein (APP) that is embedded in the cell membrane. In a benign
pathway, an enzyme, α secretase, cleaves APP producing and releasing sAPPα in-
tracellularly for neuronal growth and survival. Another enzyme, γ secretase cleaves
the remaining piece in the membrane into two peptides. The smaller peptide is re-
leased extracellularly and is harmless. In the malignant pathway, β secretase enzyme 25
cleaves APP at an errant location producing sAPPβ. The γ secretase then cuts the
remaining pieces. The produced peptide, Aβ aggregates extracellularly forming Aβ
plaques. These Aβ oligomers grow large enough to form fibril like structures and to
obstruct surrounding neuronal function.
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In contrast to Aβ plaques which build up extracellularly at the synapses of
neurons, the neurofibrillary tau angles are protein aggregates inside the cell. Tau is
a peptide that, in normal conditions, stabilizes the microtubule in neurons. When
hyperphosphorlation occurs, tau disengages from microtubules and aggregate into
phosphorylated tau (P-tau) threads that aggregate with other threads to form helical 35
structures. These helical structures eventually aggregate to form tangles. Without
functioning tau and microtubules, neurons implode disrupting neuronal pathways.
This process is known as tauopathy and leads to many forms of dementia, however,
the majority of cases leads to AD.
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1.1.1 Therapeutic approaches40
There are several impeding factors to developing therapies for Alzheimer’s
disease which include the long time (up to 20 years) needed to observe disease pro-
gression in Alzheimer’s, challenging feat of delivering drugs through the blood-brain
barrier, and lack of understanding of AD pathogenesis for targeted disease-modifying
treatments. [11] Currently six drugs are approved by the U.S. Food and Drug Ad-45
ministration (FDA) that temporarily improve symptoms of AD by increasing neuro-
transmitters in the brain. However, the effectiveness varies among patients. There
are several drugs undergoing clinical trials to modify the disease process for exam-
ple by use of immunotherapy, amyloid aggregators, and tau aggregation inhibitors.
Also, treatments to slow or stop the progression of AD and preserve brain function50
will be most effective when administered during the preclinical and mild cognitive
impairment (MCI) stages of the disease. In 2013, FDA released a draft guidance for
industry to develop drugs for the treatment of early stage AD [2] which calls for the
exploration of new biomarkers for evaluation of these drugs. There is a pressing need
to discover specific and more sensitive biomarkers to evaluate these drugs effectively55
at earlier stages.
1.1.2 Current diagnostic procedures
Psychopathology: A variety of approaches and tools are used to help make
diagnosis of AD. The 1984 diagnostic procedure had initially only included psy-
chopathological evaluations such as a medical and family history from the individ-60
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ual, psychiatric history, input about changes in thinking skills or behavior from
someone close to the individual, cognitive tests, and physical and neurologic ex-
aminations. [61] Recently, the diagnostic criteria was updated to include imaging
techniques [84] and physicians refer to medical resources such as the DSM-5. [1] We
review a few of the added techniques here. 65
Anatomical Imaging: Computed tomography (CT) and magnetic resonance
imaging (MRI) are recommended for use in detecting intercranial lesions or other
deases that may cause dementia symptoms such as cerebrovascular disease and tu-
mours as an exclusion technique. More novel uses of anatomical MRI has also
been used to visualize atrophy differences in the medial temporal lobe in patients 70
with AD and age-matched individuals with a sensitivity and specificity >85%. [90]
However the differences between AD and non-AD dementia are not clear using this
technique. Other quantitative techniques use volumetric imaging. Three dimen-
sional (3D) mapping of the hippocampus and cortical thickness measurements are
promising markers for AD and are currently under investigation at the Alzheimer’s 75
Diseases Neuroimaging Initiative (ADNI). [68,79]
Cerebrospinal Fluid Analysis: Aβ peptides and phosphorylated tau (P-tau)
have been studied in cerebrospinal fluid (CSF) and independent studies have shown
that AD can be differentiated from other dementias by detection of lower concen-
trations of Aβ1−42, higher concentrations of total tau (T-tau), and higher concen- 80
trations of P-tau at theonine 231 and 181. [11] This technique had a sensitivity of
83% and specificity of 72%. [57] Another longitudinal study showed that early AD
patients with MCI could be identified with a sensitivity of 95% and specificity of
4
83% studying the combination of T-tau, P-tau, and Aβ1−42 in CSF. [37]
Functional Neuroimaging: Positron Emission Tomography (PET) with fluo-85
rodeoxyglucose (FDG) has been approved by FDA for use in USA for diagnostic
purposes in detecting early stage AD. FDG-PET has shown good accuracy in dif-
ferentiating AD patients from age-matched control individuals. The described AD
diagnostic criterion is a reduction of glucose metabolism in the bilateral temporal
parietal regions in the posterior cingulate cortex. Meta-analysis has shown this tech-90
nique to have a sensitivity and specificity of 86% for AD diagnosis however there are
many variations between studies. This technique did not perform as well for differ-
entiating AD with other dementia. PET with 11C-labelled Pittsburgh compound B
(PIB) and 18F-labelled Aβ ligand can be used to directly visualize Aβ in vivo. [80]
However, PET has low spatial resolution and low specificity.95
99mTc-HMPAO or 133Xe with single-photon emission CT (SPECT) has shown
a lower clinical accuracy of 74% for AD patients and control individuals. [24] How-
ever it is a useful technique to differentiate AD from other dementia. The use of
dopamine transporter with 123I-fluoropropylcarboxy-metoxynortropane in differenti-
ating Lewy bodies dementia and Parkinson’s disease from AD was sufficient enough100
to be included in the diagnostic criteria for Lewy bodies dementia. [59,60]
There have been significant advancements in diagnostic tools available for AD.
We aim to study the feasibility of an additional complementary tool to assist with
the study of this disorder.
Small-angle x-ray scattering (SAXS) imaging has the potential to advance105
molecular imaging for applications where both depth and high-resolution are re-
5
quired without the use of contrast probes. SAXS can characterize and selectively
image structures based on electron density maps which allows for distinguishing
materials based on their scatter properties [6, 47].
Well-characterized SAXS profiles of AD plaques could potentially serve as 110
early detection in vivo biomarkers. The SAXS signals for the AD proteins Aβ and
tau and their various aggregate states have not yet been described in vitro nor
in tissue. The applicability of the SAXS imaging technique for AD depends on
a differentiating generalized scatter profile for AD aggregates in the brain. This
thesis aims to study the feasibility of utilizing this molecular imaging technique for 115
detection of AD plaques in vivo.
1.2 Primer on SAXS
X rays were first discovered by Roentgen in 1905 [72] and has since been
utilized for a variety of applications medical diagnostics (2D radiographic [21] and
3D tomographic [41] medical imaging) and for nondestructive inspection. X rays are 120
electromagnetic waves with much shorter wavelengths, λ, than visible light (between
0.1 to 10 nm). X rays are also interpreted in terms of photons of energy, E (eV),





where h is Planck’s constant, 6.62×10−34 (joules s) and c is the velocity of light,
2.998× 108 (m/s). Because of their high energy and short wavelengths, they are 125
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able to penetrate through thicker and denser objects than visible light and provide
information at the atomic length scale. Similarly to visible light, x rays are either
transmitted through objects unperturbed, or interact with the objects by absorp-
tion or scattering events. These events can be modelled by probability distribution
functions which depend on the electron density of the material and the wavelength130
of the x rays.
Conventional medical imaging applications largely differentiates materials based
on their absorption properties providing micrometer scale morphological spatial in-
formation and scattering has traditionally been treated as noise to these systems.
Research efforts have therefore been to remove x-ray scattering events by collimation135
and post-processing. However, a limitation of these absorption-based approaches in
medical diagnostics is that many pathologies share similar attenuation characteris-
tics with normal surrounding tissues, especially during early disease stages where
change occurs at molecular and cellular levels. Conversely, in x-ray diffraction and
crystallography, material nanoscale size, shape, structure, and periodicity has been140
studied by measuring x-ray scattering and absorption is minimized to maximize
scatter signal.
1.2.1 Absorption
Absorption occurs when an x ray ejects an electron from the electron cloud of
an atom in the material it travels through. This event is known as the photoelectric145
effect. The energy that the x ray possessed is transferred completely to the electron
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which is expelled and the atom rearranges the remaining electrons to fill the electron
hole. If an electron from an inner shell is ejected, an electron from an outer shell will
move in to fill the hole at inner shells and the atom will emit fluorescence radiation
to balance the energy of the event. The emitted fluorescence is an x ray with a 150
different energy than that of which was absorbed. The probability that absorption
occurs depend on the energy of the x ray and material density. The fraction of x




where I0 is the initial number of x rays before traversing through a material, I, is
the number of x rays recorded after traversing through the material at the same 155
angle of I0, µ is the mass absorption coefficient of the material dependant on λ, ρ
is the density of the material, and x is the thickness of the material. This absorp-
tion coefficient increases with increasing λ, except at characteristic fluorescent x ray
wavelengths. µ is the material-dependent property that is often exploited in con-
ventional x-ray radiography for differentiation of tissue types. In x-ray diffraction 160
studies, material thickness is adjusted to minimize absorption effects. The optimal







There are two kinds of x-ray scattering that can occur: Rayleigh scattering and
Compton scattering. Rayleigh scattering, also called coherent scattering, scatters165
x rays such that the x ray changes direction, but not energy whereas Compton
scattering, or incoherent scattering, typically scatters at wider angles and energy
of the x ray is reduced after the scattering event. The Rayleigh scattering angular
range has been further categorized to ultra small-angle x-ray scattering (USAXS),
small-angle x-ray scattering (SAXS), and wide-angle x-ray scattering (WAXS) by170










Figure 1.1: Schematic of scattering domains.
Fig. 1.2 shows a typical SAXS system which includes a monochromatic x-ray
source, a collimation system to focus the x-ray beam, a beamstop to attenuate a
portion of the primary transmitted x rays, and a detector to measure the scattered175
x rays from interaction with a sample. The collimation could be a series of pinholes,
or blocks and they are used to form pencil beams or line beams. Line beams are
used because they increase the number of x rays that pass through the sample,
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thereby shortening measurement times, however line-collimated SAXS data requires
an additional desmearing post-processing step adding uncertainty to the data. On 180
the other hand, point-collimated pencil beams do not generally need a desmearing
step. The beamstop protects the detectors from burn-in by the primary x rays
















Figure 1.2: Schematic of a typical transmission SAXS system enclosed in vacuum.






where p0 is the pixel at the center of the primary beam, and pn is the number of pixels
away from the center pixel. px is the pixel pitch and the d is the sample-to-detector
distance.
















where θ is half of the scattering angle as depicted in Fig. 1.3. The scattering vector is
used over 2θ because it accounts for the wavelength of the x-ray source and maintains
consistency of scatter profiles between various instrument geometries and energies
used.195
For randomly oriented scatterers, the 2D scatter is isotropic and can be reduced
to a 1D scatter profile by radially averaging. For anisotropic, oriented scatterers, the
2D scatter image will not be radially symmetric, therefore should not be reduced to
a 1D scatter profile. Fig. 1.4 shows an example of anisotropic and isotropic signals
that we have measured of mouse brain tissue and glassy carbon respectively.200
Intensity of x-rays is defined by the flux of energy crossing a unit surface
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Figure 1.4: An example of anisotropic scatter from mouse brain tissue and isotropic
scatter from glassy carbon respectively.
volume per second. The intensity of scatter is described as the following,
Is(q) = I0nρ
2V 2F 2(q)S(q), (1.6)
where n is number of particles, ρ is the particle electron density, V is the particle
volume, and F (q) is the form factor which informs particle shape and size, and S(q)
is the structure factor which accounts for interference effects of multiple particles in 205
close proximity.
To subtract scatter contributions from the instrument and sample holder, often
times a scatter profile is obtained for the background, bg, which is scaled to the
sample scatter profile by the primary beam, then subtracted,
I(q) = Is(q)− Ibg(q)Tf , (1.7)
where Tf is the transmission scaling factor. These steps are shown in Fig. 1.5. In 210
this case, we observe the change in electron density of the scatter profile, ∆ρ, which
provides contrast to the background scattering.
The primer on SAXS was developed from the following sources. [26, 33, 36]
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Figure 1.5: Scaling and background subtraction data treatment.
Additional corrections due to geometric distortions and detectors are performed to
the scatter intensity. [65]215
1.3 Thesis scope
In this chapter, we introduce Alzheimer’s disease, the impact it has on our
society, the motivation for our study to present a novel approach to imaging this
disorder by molecular changes occurring in the brain, and the general theory of
SAXS.220
In chapter 2, we present SAXS measurements of isolated peptides of Aβ and
tau in vitro in various buffer solutions. We discuss decisions made to focus on Aβ
and on ex vivo tissue rather than in vitro as these peptide aggregate structure in
buffer solutions may not accurately describe what happens in vivo.
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In chapter 3, we introduce simulations of x-ray transport that allows us to 225
study instrument design and optimal sample thickness that will enable us to discern
a signal of interest from nanoparticles in a transmission SAXS system and also for
SAXS in computed tomography (CT) geometry. This work is published in Journal
of Applied Crystallography.
Chapter 4, we simulate a simplified SAXS-CT system for detection of dilute 230
gold spherical nanoparticles in water.
Chapter 5 presents planar SAXS imaging measurements of a developed phan-
tom with known cross sections and demonstrates feasibility of planar SAXS to dif-
ferentiate materials and increase signal based on material scattering cross sections.
This work was published in Applied Physics Letters. 235
Chapter 6 presents our measurements of planar SAXS on slices of normal ex
vivo mouse brains. We segment different tissue regions in the planar SAXS image
and characterize cross sections of the white matter, gray matter, and corpus callosum
in the mouse brain.
In chapter 7, we demonstrate the ability of planar SAXS to measure amyloid 240
fibrils in a mouse brain. Transgenic Alzheimer’s disease mouse model and wild-type
mice brains are measured and compared.
Finally, in chapter 8, we conclude our work and present outlooks for SAXS-CT
and it’s feasibility for detection of molecular changes in the brain for application of
Alzheimer’s disease. 245
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Chapter 2: Preliminary in vitro SAXS measurements of Aβ and Tau
There is a need for novel imaging techniques for the earlier detection of Alzheimer’s
disease (AD). Two hallmarks of AD are amyloid beta (Aβ) plaques and tau tan-
gles that are formed in the brain. Well-characterized x-ray cross sections of Aβ
and tau proteins in a variety of structural states could potentially be used as AD250
biomarkers for small-angle x-ray scattering (SAXS) imaging without the need for
injected probes or contrast agents. In this chapter, we report SAXS measurements
of Aβ42 and tau352 in a 50% dimethyl sulfoxide (DMSO) solution in which these
proteins are believed to remain monomeric because of the stabilizing interaction
of DMSO solution. However, our SAXS analysis showed the aggregation of both255
proteins. In particular, we found that the aggregation of Aβ42 slowly progresses
with time in comparison to tau352 that aggregates at a faster rate. Furthermore, the
measured signals were compared to the theoretical SAXS profiles of Aβ42 monomer,
Aβ42 fibril, and tau352 that were computed from their respective protein data bank
structures. We have begun the work to systematically control the structural states260
of these proteins in vitro using various solvent conditions.
While various peptide lengths of Aβ exist, we initially study the Aβ42 isomer
because it is the most fibrillogenic and therefore most associated with amyloid load.
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There are also six isoforms of tau that depend on phosphorylation epitopes. Not
much is understood about how each of these protein isoforms affect AD. They take 265
on various structural forms and could potentially be differentiated in SAXS imaging
which may give insight into their role in AD. We have focused our study on the
smallest isoform, tau352. Aggregation of these proteins has been reported to depend
on sample temperature, solvent pH, ionic concentration, and time. [4,89,92] There-
fore, the environment and solvent conditions have been controlled in order to obtain 270
SAXS signals for the AD proteins at specific aggregate states.
2.1 Methods
Lyophilized powder form of human tau352 peptide (Abcam, Cambridge, UK)
and human Aβ42 peptide (Anaspec, Fremont, CA) were stored at -20
◦C before
sample preparation. We dissolved the proteins in 50% DMSO (pH 8) because they 275
were reported to remain monomeric in this solvent. [82] Aβ42 was dissolved with a
concentration of 5.6 mg/ml and tau352 was dissolved with a concentration of 1.43
mg/ml. Each sample was loaded into a 1 mm diameter quartz capillary and held in
a temperature-controlled sample holder at 37 ◦C.
SAXS measurements were performed using SAXSpace (Anton Paar, Ashland, 280
VA, USA). The instrument, which uses Cu Kα radiation (λ = 0.154 nm), was con-
figured in Kratky block point collimation mode with an accessible q range of 0.14–
2 nm−1. The system is equipped with a CCD camera with a pixel pitch of 24 µm
in an array of 2084×2084 pixels. The camera uses a Gd2O2S:Tb phosphor screen
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optimized for 8-keV X rays. The sample holder was positioned at a distance of285
305.3 mm from the CCD. The collimation system, sample chamber, and beam path
were enclosed in vacuum with a pressure below 3 mbar. The CCD pixels were binned
along the length of the beam (2 cm). SAXS measurements were obtained with an
exposure time of 5 s and 200 frames for each protein. The samples were measured 5
min after preparation and again after 4 days. Between measurements, the samples290
were stored at room temperature.
Preliminary data treatment of scatter profiles including solvent background
and dark current subtraction were performed in SAXStreat (Anton Paar, Ashland,
VA, USA) and SAXSquant (Anton Paar, Ashland, VA, USA). Subsequent data
analysis for measurements included beam desmearing, fitting approximations, and295
obtaining pair distance distribution functions, P (r), using indirect Fourier trans-
form. [31] Guinier analysis [34] was performed using custom code written with MAT-
LAB R2015a (The MathWorks Inc., Natick, MA) to obtain information about the
radius of gyration, Rg, of the protein. A larger Rg than what is expected based on
the protein’s monomeric structure is one indicator of aggregation.300
In the Guinier approximation of Rg, a q range of 0.001-0.399 nm
−1 was used for
Aβ42 sample measured after 5 min and the PBD data of Aβ42 where q = 4πsin(θ)/λ.
A q range of 0.001-0.200 nm−1 was used as a low angles for the Aβ42 sample measured
after 4 days, and 0.300-0.400 nm−1 was used for wider angles because more than
one slope region was observed. For all tau352 samples, a q range of 0.001-0.140 nm
−1
305
was used at low angles, and 0.270-0.310 nm−1 was used for wider angles.
The Rg was also calculated for each sample using the electron pair distribution
17
function, P (r), which provides information on the average protein shape in the










where Dmax is average maximum electron pair distance the value of r when 310
the P (r) returns to zero.
As a comparison to our measurements of Aβ42 and tau352 in DMSO, we ob-
tained the protein data bank (PDB) files of Aβ42 peptide (1IYT), Aβ42 fibrils
(2MXU), tau352 (1B5L) and simulated their scatter profiles from the given pro-
tein structures using FoXS web server. [74] FoXS computes a SAXS profile using 315
information of a protein from a PDB file and the Debye formula. Scattering from
the hydration layer around protein and the excluded volume are considered in the
Debye model by incorporating them as adjustable parameters in the form factor to
estimate a SAXS profile. All of the scatter profiles from PDB files were computed
with default parameters. By default, the maximum q value was 5 nm−1 and we used 320
500 points to generate each SAXS profile.
2.2 Results
We present the SAXS signals acquired and analyzed for Aβ42 and tau352 within
50% DMSO. Fig. 2.1(b) shows the SAXS signals for Aβ42 in DMSO solvent (pH 8) at
37 ◦C after 5 min and after 4 days. The FoXS generated SAXS profiles of the Aβ42 325
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Figure 2.1: (a) Representation of the protein structures of Aβ42 monomer (PDB
1IYT) in pink and fibril (PDB 2MXU) in green. (b) SAXS profiles for Aβ42 from
crystal structures of monomer and fibril obtained from the FoXS using PDB files,
and from SAXS measurements of Aβ42 protein in DMSO after 5 min and after 4
days. The curves have been offset for clarity by factors of 101.3, 10−1.9, 104, and 102
respectively. (c) Guinier plots with reported Rg of Aβ42 monomer and fibril crystal
structures from PDB, and from SAXS measurements after 5 min and after 4 days.
The curves have been offset for clarity by factors of 103, 102, 5 × 104, and 5 × 103
respectively. (d) P (r) of Aβ42 for monomer and fibril crystal structures from PDB,
and from SAXS measurements after 5 min and after 4 days.
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as shown in Fig. 2.1(c), the Rg values of the proteins can be extracted from the slope
of linear fit. Fig. 2.1(c) shows that the Rg value of Aβ42 increases from 6.2 nm to
9.2 nm after 4 days of measurement, indicating slow progression of aggregation with
time. The Guinier curve of Aβ42 after 4 days cannot be fitted with a single straight 330
line and shows two different Rg values (9.2 nm and 4.5 nm) in the low q region. This
strongly suggests the formation of aggregates of two different size. Moreover, the
experimentally measured Rg value of Aβ42 after 5 min is approximately four times
bigger than of its own monomer crystal structure (PDB 1IYT). Interestingly, the
size of the Aβ42 fibril crystal structure (PDB 2MXU) is also approximately three 335
times smaller than that of Aβ42 measured after 5 min.
Fig. 2.1(d) shows the P (r) of the SAXS profiles for Aβ42. We report the Rg
values calculated using Eq. 2.1. The Rg values calculated for Aβ42 are similar to
those calculated in Guinier analysis for the respective samples. In addition, both
functions for the experimental samples have a wider spread for r and a shoulder 340
at the right tail end of the curve in comparison to the theoretical P (r) calculated
from their crystal structures. Dmax of Aβ42 after 5 min is at least three times bigger
than that of its monomeric crystal structure. Similarly, as shown in Fig. 2.1(d),
Aβ42 after 4 days has a wider spread than when it was measured after 5 min. This
result suggests that Aβ42 aggregation increases over time and we can use SAXS 345
to characterize this aggregation. Nevertheless, it also suggest that the expected
trend for Aβ42 aggregation derived from their crystal structures is not consistent
with experimental results. We observe the effect of protein-protein interaction and
induced aggregation from features in the distribution, specifically by the shoulder
20
at the right tail of the curve and by the Dmax.350
Fig. 2.2(b) shows the SAXS signals for tau352 in DMSO solvent at 37
◦C
measured after 5 min and after 4 days. The FoXS generated SAXS profiles of the
tau352 monomer is also shown for comparison. In Fig. 2.2(c), Rg values around
14 nm were calculated for measured tau352 SAXS profile in the low q region. A
second Rg was estimated by Guinier analysis to be 9-14 nm in a wider q region,355
which is significantly larger than the expected 1.6 nm determined from its monomer
crystal structure, indicating significant aggregation of tau352 in DMSO.
Fig. 2.2(d) shows the P (r) of the SAXS profiles for tau352. As observed with
Aβ42, the Rg values calculated for tau352 are close to those calculated in Guinier
analysis for respective samples. The Rg values calculated through both Guinier and360
P (r) analysis were similar. In addition to this, the P (r) of tau352 measured after
5 min and then after 4 days appear nearly identical, indicating little to no change
in aggregation over the course of 4 days. The characteristic symmetry and large r
at the maximum peak of the P (r) suggest that, for both time points, tau352 formed
large, spherical oligomers and that tau352 may have already reached steady-state365
aggregation.
2.3 Discussion
The results of this study show that various aggregation levels of AD proteins,
Aβ42 and tau352, can be characterized with SAXS. In this paper, we focused on
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Figure 2.2: (a) Representation of protein structure for tau352 monomer (PDB
1B5L). (b) SAXS profiles from crystal structure of monomer obtained from FoXS
using PDB file, and from SAXS measurements of tau352 protein in DMSO after 5
min and after 4 days. The curves have been offset for clarity by factors of 1, 102, and
104 respectively. (c) Guinier plots with reported Rg for monomer crystal structure,
and for SAXS measurements after 5 min and after 4 days. The curves have been
offset for clarity by factors of 107, 105, and 103 respectively. (d) P (r) of tau352 for
monomer and fibril crystal structures from PDB, and from SAXS measurements
after 5 min and after 4 days.
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hypothesized to remain monomeric because of the stabilizing interaction of DMSO
and the high pH of the solution. One likely reason behind this is that DMSO at
this concentration preferentially binds to the hydrophobic side chains of the amino
acids and prevent the hydrophobic interaction which is one of the driving forces of
protein aggregation. On the other hand, pH changes in the solution modulates the375
electrostatic interaction among proteins depending on their individual net charge.
For instance, in the case of pH 8, the net calculated charge of Aβ42 is -3.4. Due to
their negative charges, there should be an effective repulsion among Aβ42 proteins
to maintain their native monomeric states. Nevertheless, aggregation for both Aβ42
and tau352 samples were observed with SAXS in the 50% DMSO solution contrarily380
to what we expected.
Our SAXS analysis suggests aggregation of both Aβ42 and tau352. In particu-
lar, we found that tau352 aggregates at a faster rate to reach the steady state after
5 min, whereas Aβ42 aggregation slowly progresses with time. One possible reason
behind the aggregation is due to the concentration effect. The concentration of Aβ42385
and tau352 were 5.6 mg/mL and 1.43 mg/mL respectively. Due to their high con-
centration, the aggregation is likely to occur despite the unfavourable hydrophobic
interaction and electrostatic repulsion imposed by the solvent. The concentration
of DMSO in water was not high enough to bind to every peptide present at high
concentration to prevent the aggregation. In any case, the concentration depen-390
dent study of both protein and DMSO needs to be done to further understand the
mechanistic part of protein aggregation shown by SAXS data.
The differences in scatter profile between measured samples and PDB could be
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attributed to the fact that calculations of scatter using the PDB are of a single pro-
tein in every orientation averaged, whereas, experimental measurements are more 395
complex containing of a distribution of protein aggregates, orientation, and confor-
mations. In addition, a nuclear magnetic resonance technique was used to inform
the PDB file for these proteins. Therefore, differences between the measured sizes
of the protein and the PDB information could be due to differences in measurement
techniques. 400
Future work includes validating the measurements obtained with repeat mea-
surements, as well as with other laboratory techniques including dynamic light
scattering (DLS), UV-vis spectroscopy, and thioflavin T fluorescence assay. Also,
we plan to compare measurements of these proteins taken at different time-points
for AD proteins dissolved in a variety of solvents. After characterizing the SAXS 405
measurements of these AD proteins at various aggregation in steady-state, the ob-
tained scatter signals will be converted to absolute cross sections using a water
standard.These cross sections can then be converted to input material files for MC-
GPU simulations to determine feasibility of AD imaging in vivo with various sample
and instrument geometries. [9, 19] 410
2.4 Conclusion
We report SAXS measurements of Aβ42 and tau352 in 50% DMSO at two time
points. 50% DMSO was initially chosen as a buffer because proteins are reported
to remain monomeric in this solution, however we observed aggregation and growth
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between measurements at 5 min after sample preparation, and 4 days. The signals415
measured even after 5 min were different than theoretical scatter profiles generated
using PDB structures. β amyloid and tau were difficult to control in vitro and may
not behave the same way in vivo, therefore, we determined it would be more useful
to measure the plaques and tangles ex vivo for a closer approximation to our target
signals in vivo.420
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Chapter 3: Incorporating experimental cross sections into MC x-ray
transport calculations
In this chapter, we describe and validate a fully detailed Monte Carlo x-ray
transport simulation technique that utilizes user-provided cross sections to describe
x-ray interaction in virtual samples and explore SAXS instrument design choices. 425
We validate the accuracy of the simulation code with sample material cross sec-
tions derived from analytic models and empirical measurements of a homogeneous
spherical gold nanoparticle (GNP) monomer, dimer, and heterogeneous mixtures of
the two in a water solvent. Analytic and measured scatter profiles from these sam-
ples were converted to cross sections using an absolute water standard. Our Monte 430
Carlo estimates of the fraction of dimers from analytically-derived and empirically-
derived cross sections are strongly correlated with less than 1.5% and 16% error
respectively to the expected concentration of monomer and dimer species. In addi-
tion, we simulated a variety of monoenergetic x-ray beams to investigate coherent
scattering versus radiation dose for a range of sample sizes. For GNP spheres in 435
a water solvent, the energy range that produces the most coherent scatter at the
detector per deposited energy was between 31 and 49 keV for sample thickness of
1 mm to 10 cm. The method we describe for the detailed simulation of SAXS using
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measured and modeled cross sections will enable instrumentation optimization for
in vivo molecular imaging applications.440
3.1 Introduction
There are an increasing number of imaging applications for small-angle x-ray
scattering (SAXS) using scanning [32] and tomographic methods [46, 75]. We have
proposed a particular biomedical application that utilizes SAXS molecular imaging
of probed protein-protein interactions [6]. SAXS imaging is a promising alternative445
tool for in vivo molecular imaging because the coherent scatter provides nanostruc-
tural information about a sample without the need for destructive sample prepa-
ration techniques. Other biomolecular interaction characterization methods, such
as positron emissions tomography (PET), fluorescence resonance energy transfer
(FRET), and bioluminescence resonance energy transfer (BRET), have low spatial450
resolution, poor specificity, or inherently lack the capability for deep tissue imaging.
Well-defined SAXS signatures from high-contrast molecular probes, such as gold
nanoparticles (GNPs), could be correlated with the presence of biomolecular inter-
actions and provide a higher specificity option that is able to image protein-protein
interactions in vivo in deep tissue. It was demonstrated that GNP signals could be455
determined even within a complex background such as E. coli lysate [6]. However,
concerns remain regarding the long measurement times and the excessive amount of
energy deposited into live samples. Simulations of the entire SAXS imaging chain
allow us to study various instrumentation geometries for a given application without
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time, safety, and monochromatic source energy limitations typical of measurements. 460
We present a code that simulates x-ray transport from source to detector in a
SAXS instrument. The code allows user-provided cross-sections derived from mea-
surements or analytic models to describe how the x-ray interacts in voxelized virtual
samples. For more complex biological materials that cannot be described analyti-
cally such as soft tissue, adipose, and bone, this construct allows users to measure 465
cross sections of materials individually with optimal sample thickness and instru-
ment settings and then simulate a more realistic sample geometries which includes
effects from multiple materials superimposed. We validate the simulations with well-
defined cross sections consisting of a homogeneous gold nanoparticle (GNP) sphere,
dimerized GNP spheres, and the weighted sum of the former two cross sections in 470
ratios of 2:1, 1:1, and 1:2 in a water solution as non-interacting and interacting
SAXS signals at varying levels. These cross sections are derived both from analytic
modeling and from measurements of GNP spheres with radius of 6.75 nm in water,
dimerized GNPs in water with similar concentration, and the two former solutions in
the same aforementioned volumetric ratios as the model. We describe the procedure 475
of converting scatter intensity profiles to cross sections that can be used as inputs
to the simulations. After simulation of the SAXS instrument measurement of vir-
tual samples, a previously developed method [6] was used to extract from scattering
profiles the required information regarding the fraction of interacting particles in a
solution and the size of monomers and dimers. 480
To illustrate the use of our tool, we explore the effect of varying the monochro-
matic source energy and the sample thickness and evaluate deposited energy and
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intensity of coherent x rays when varying parameters of energy and sample thickness.
3.2 Methods
3.2.1 SAXS simulations485
The code we present is based on MC-GPU [9], a publicly available GPU-
accelerated x-ray transport simulation tool that is used to generate clinically-realistic
images and radiation dose estimations for a number of x-ray imaging modalities (Ra-
diography, Computed Tomography [10], Digital Breast Tomosynthesis [64]). It uses
Monte Carlo techniques to simulate large number of x ray trajectories which interact490
with material atoms in a voxelized geometry based on advanced physics models from
PENELOPE 2006 [73]. The x-ray path is determined by random sampling proba-
bility distribution functions that decide whether the x ray is scattered, transmitted,
or absorbed. Cross sections of the materials the x ray travels through is used to
determine these probability distribution functions. The inherent benefit of this tool495
is that it allows for separation of primary, Compton, Rayleigh, and multiple-scatter
x rays contributions, a dose estimation on the sample, use of a complex voxelized
sample geometry, the inclusion of realistic source and detector models, and study of
various collimation geometry effects.
The form factors for homogeneous materials are by default calculated in MC500
codes with an independent atomic approximation (IAA) which combines the form








where nZ is the weight fraction of element Z, FZ(q) is the atomic form factor for





where λ is x-ray source wavelength, and 2θ is scattering angle.
To simulate realistic x-ray scattering from particles, molecules, and tissues
at small angles, MC-GPU was modified to allow user-provided cross sections of
materials that that capture both the form factor and the structure factor effects [28].







where dσT/dΩ is the classical Thomson cross section for scattering by a free electron
at rest, and structure factor, s(q), accounts for the interference effects between the
scattered photons.
3.2.2 Cross sections
Empirical measurements and analytic scatter models of a controllable sur- 515
rogate protein-protein interaction system consisting of monomeric GNP spheres,
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dimerized GNP spheres, and a mixed ratio of these two particles are used to gen-
erate cross sections for validation of the simulations of SAXS using MC-GPU. We
simulate a full SAXS instrument using theoretical and measured cross sections of
samples.520
3.2.3 Empirical measurements
The sample system was synthesized monomeric GNP spheres with radius of
6.75 nm and dimerized GNP spheres of same radii dissolved in water. The concen-
tration of the GNP monomer and dimer solutions were both 7.0× 1011 ± 0.5× 1011
GNPs per mL as estimated by UV-Vis. The two solutions were mixed with volumet-525
ric ratios of 1:0, 2:1, 1:1, 1:2 and 0:1. These five samples and water were empirically
measured with our laboratory SAXS instrument (SAXSpace, Anton Paar, Ashland,
VA, USA). The instrument utilizes a Cu Kα radiation (λ = 0.154 nm) and was
configured in Kratky block line collimation mode. The CCD camera had a pixel
pitch of 24 µm in an array of 2084x2084 pixels. Samples were loaded into the system530
via a 1-mm diameter quartz capillary positioned at a distance of 305.3 mm from
the CCD. The accessible q-range was 0.0732–1.66 nm−1. The entire beam path was
enclosed in vacuumed space with a pressure below 3 mbar to limit undesirable scat-
ter from air. The CCD pixels were binned along the length of the beam (2 cm).
For each measurement, 2400 frames were obtained at 1 s exposures and averaged.535
The smeared line-collimated data was desmeared using indirect Fourier transform
method [31] with 20 splines between 0 and the a priori estimate of the longest pair
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distance in the particle, Dmax. Dmax was initially estimated and then adjusted until
the p(r) shown near Dmax did not descend sharply, go negative, or oscillate. We used
29 different stabilization values, α, of 10n for n from -4 to 10 in steps of 0.5 which 540
we found to be a sufficient range in finding an appropriate α and set of weights. The
appropriate α chosen was determined by following procedures outlined by Glatter
et. al [31]. The α for the probe solution was 5, and ranged between 2.5 and 4.5 for
the dimer solution and mixes.
3.2.4 Analytic models 545
As a noise-free comparison, scatter profiles of GNP monomer spheres, dimers,
and the mixture of the two were also analytically-derived using spherical form factor
and a dimer structure factor. To calculate the analytic model scatter of the GNP





where R is the sphere radius. We chose a R of 6.75 nm which was the approximate 550
radius of our GNP samples. The scattering intensity of spheres, Im, is described by
Im(q) = KF
2
m(q, R), where K = n∆ρ
2V 2 (n is the number of particles, ∆ρ is the
difference in electron density between particles and solvent, and V is volume of a
particle). For our model, K was a scaling factor to the scattering intensity of our
measured scatter of GNP spheres. We applied a structure factor to take into account 555
the interference effect of two interacting spheres. The structure factor multiplied by
32
Im is the scattering intensity of a dimer [48],







where s is the center-to-center spacing of the spheres in a dimer. For our model,
we chose s =20 nm which is within a range of distances at which proteins interact.
The SAXS profile for a our sample material, IM(q), is the weighted sum of the560
contributions from monomers, Im(q), and dimers, Id(q):




where ω is the weight for relative monomer concentration and dimer concentrations
with a distribution of center-to-center spacings, s.
3.2.5 Absolute scaling by secondary water standard
Scatter intensity profiles of model and measured cases were converted to ma-565














(q) is the differential cross section of the material of interest, IM(q) and




known differential cross section of water which is relatively constant at 0.01632 cm−1570
within the q-range 0–12 nm−1. IM(0) and IW (0) are the primary beam intensities
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of the material and water respectively.
The scatter intensity of both analytic model and experimentally measured
samples are converted to cross sections to be assigned to sample material voxels in
the simulations. The MC estimates of both the modeled and measured cross sections 575
are compared to evaluate the performance of the MC acquisition model.
3.2.6 Validation
The geometry of the SAXS instrument is shown in Fig. 6.1 The distance of
the front edge of the sample to the detector was fixed at 29 cm. The x-ray source
was an infinitely small monochromatic pencil beam. The x-ray energy used was 580
8 keV. The detector was 2x2 cm2 with 1200x1200 pixels and had 100% detection
efficiency. Fig. 3.2b shows a block diagram of the inputs to MC-GPU. The sample
geometry was a 1x1xz cm box where z is the thickness along the beam path. For
the study of interaction fraction of our analytic models and empirical data, we used
z = 1 mm which is the thickness of our instrument capillary. 1012 primary x rays 585
were simulated for each SAXS acquisition and took approximately 6 minutes to
complete in our computer containing 6 NVIDIA GeForce GTX Titan GPUs. The
image at the detector was radially averaged. The process was repeated 10 times for
calculating the statistical uncertainty.
We extended the validation of simulated SAXS profiles to an interaction frac- 590
tion figure-of-merit [6] which in our application quantifies the fraction of dimers
























(b)Block diagram of inputs and outputs of SAXS MC-GPU.
FIG. 1. Schematic of the simulated geometry and block dia-
gram of MC-GPU. IM (q) and IW (q) are the empirical scatter
profiles for a material of interest and water. I∗M (q) is the sim-
ulated scatter profile. D∗M is the calculated total dose on the
sample.
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where s is the center-to-center spacing of the spheres in94
a dimer. For our model, we chose s =20 nm. A weighted95
sum of these scattering curves was used to create mix-96
tures of monomer and dimer curves representing differ-97
ing levels of interaction which we define as interaction98
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and 1 which were the estimated volumetric fractions for100
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FIG. 2. Scatter profile of the analytic (IM ) model of GNP
spheres in water and average scatter profile of 10 simulations
(I∗M ) of that model. From bottom to top the scatter is of
water, GNP monomer, 2m:1d, 1m:1d, 1m:2d, and dimer in
a water solvent. Error bars are the standard deviation of
10 repeated simulations for every 50 points for clarity. The
simulated scatter profiles match the inputted scatter profiles
from analytic models giving indication there is little bias from
SAXS MC-GPU simulations.
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FIG. 1. Schematic of the simulated geometry and block dia-
gram of MC-GPU. IM (q) and IW (q) are the empirical scatter
profiles for a material of interest and water. I∗M (q) is the sim-
ulated scatter profile. D∗M is the calculated total dose on the
sample.
R of 6.75 nm which was the approximate radius of our82
GNP samples. The scattering intensity of spheres, Is, is83
described by Is(q) = KF
2
s (q,R), where K = n∆ρ
2V 2 (n84
is the number of particles, ∆ρ is the difference in electron85
density between particles and solvent, and V is volume86
of a particle). For our model, K was a scaling factor to87
the scattering intensity of our measured scatter of GNP88
spheres. We applied a structure factor to take into ac-89
count the interference effect of two interacting spheres.90
The structure factor multiplied by Is is the scattering91
intensity of a dimer,892







where s is the center-to-center spacing of the spheres in94
a dimer. For our model, we chose s =20 nm. A weighted95
sum of these scattering curves was used to create mix-96
tures of monomer and dimer curves representing differ-97
ing levels of interaction which we define as interaction98
fraction.6 The dimer fractions were 0, 0.33, 0.5, 0.66,99
and 1 which were the estimated volumetric fractions for100
dimerized GNPs in our measured samples.101
Scatter intensity profiles of model and measured cases102
were converted to material cross sections by calibrating103






× CW (q), (3)105
where CM (q) is the cross section of the material int r-106
est, IM (q) and IW (q) are the scatter profiles of the ma-107
q [nm-1]


















FIG. 2. Scatter profile of the analytic (IM ) model of GNP
spheres in water and average scatter profile of 10 simulations
(I∗M ) of that model. From bottom to top the scatter is of
water, GNP monomer, 2m:1d, 1m:1d, 1m:2d, and dimer in
a water solvent. Error bars are the standard deviation of
10 repeated simulations for every 50 points for clarity. The
simulated scatter profiles match the inputted scatter profiles
from analytic models giving indication there is little bias from
SAXS MC-GPU simulations.
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Figure 3.2: Block diagram of inputs and outputs of MC-GPU for SAXS. IM(q) and
IW (q) are the e pirical scatter profiles for a material of interest and water. I
∗
M(q)
is the simulated scatter profile. D∗M is the calculated total dose on the sample.
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||Cω − I∗M||22, (3.8)
with I∗M as the simulated scatter profile of a given material. The basis functions, 595
C, corresponding to analytic expressions for a monomer and several dimers with
varying s (see section 3.2.4), are assembled into a matrix,
C =
[
Im(q) Id(q, smin) . . . Id(q, smax)
]
(3.9)




s ωd(s) + ωm
. (3.10)
The interaction fraction of weighted sum scatter curves from the analytic model of 600
monomer and dimers matched exactly the expected dimer weights using this algo-
rithm. The dimer fractions were 0, 0.33, 0.5, 0.66, and 1 which were the estimated
volumetric fractions for dimerized GNPs in our measured samples. To improve the
realism of the simulations, we added the absolute cross section of water as a constant
(See section 3.2.5) to the analytic scatter cross sections to mimic the GNP monomer 605
and dimers that were measured in a water solution. The resulting simulated scatter
profiles were corrected by subtracting a separately simulated water scatter with the
same sample geometry.
Equation 3.8 was fit over a q-region from 0.0732–1 nm−1 with a ∆q of 0.0032.
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This range of q was selected because it contained the differentiating feature in the610
scatter profile indicative of dimers.
3.2.7 Application to instrument design
After validating MC-GPU for SAXS using analytic models and measured data,
we studied the SAXS system design varying the source energy and sample thickness.
The same instrument geometry was used as shown in Fig. 3.2a, however energy was615
varied from 5 to 95 keV in steps of 1 keV and z was varied 0.1, 0.5, 5, and 10 cm. We
used the analytic monomer scatter cross section for the sample material because it
was well defined and devoid of various sources of noise as opposed to the measured
monomer scatter. 1× 1012 primary x rays were simulated.
3.3 Results620
Fig. 3.3 shows the scatter profiles of the analytic model before and after simu-
lation. The interaction fraction of these simulated curves is shown in Fig. 3.4(a) and
Fig. 3.5. The simulation results accurately match the input analytical cross sections
with a constructed s of 20 nm. The error between simulated interaction fractions
and the weights applied to analytic monomer and dimer scatter was less than 1.5%,625
likely due to differences in the flat water cross section addition and simulated water
subtraction containing Poisson noise. This caused peaks to occur at the boundaries
of the dimer s distribution and at 21 nm.
The results from simulated measured scatter curves of our GNP samples are
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Figure 3.3: Scatter profile of the analytic (IM) model of GNP spheres in water and
average scatter profile of 10 simulations (I∗M) of that model with different monomer
and dimer ratios. From bottom to top the scatter is of water, GNP monomer, 2m:1d,
1m:1d, 1m:2d, and dimer in a water solvent. Error bars are the standard deviation of
10 repeated simulations for every 50 points for clarity. The simulated scatter profiles








































Figure 3.4: Distribution of GNP center-to-center spacing, s, for 5 scatter profiles
with different ratios of monomer ’m’ and dimer ’d’ scatter estimated from simulations
using analytically-derived cross sections (a) and empirically-derived cross sections
(b). The analytically-derived cross sections were constructed to have an s of 20 nm,
whereas the empirically-derived cross sections were found to have an s of around
32 nm.
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Volume fraction of dimer



















Figure 3.5: Correlation plot of volumetric fraction of dimers and interaction fraction
estimated from simulations using analytic and measured cross sections.
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shown in Fig. 3.4(b) and Fig. 3.5. The s of the dimers were unknown at time of630
measurements but from information gleaned from fitting analytic curves suggested
that the dimers have an s of 32 nm which coincides what was reported in our
previous work for these samples [6]. The interaction fraction error was less than
16%. The difference in this comparison could be attributed to several factors. First,
the monomer GNP solution could have a distribution of sizes. Second, there is635
likely to exist some monomer and different s dimers in our dimer solution. And
lastly, there could be an imperfect background subtraction which was also seen in
the analytically-derived cross-section simulations.
Fig. 3.6 shows the scatter profiles from simulations with varying energies and
z. The energy was varied from 5 to 95 keV in steps of 1 keV and z was selected to640
be 0.1, 0.5, 5, and 10 cm.
Fig. 3.7(a) shows the sum of scattering photons, I, within a momentum trans-
fer of 0 and 2 nm−1, over the total number of primary photons simulated for each
sample, H. The maxima in these plots are indicative of the energies that produce
the most coherent scatter within the angular range of interest for a fixed number645
of primaries which is proportional to exposure time. Fig. 3.7(b) shows the energy
deposited, ED on the sample per incident photon, H.
Fig. 3.7(c) shows the number of scattered photons over the deposited energy
(U = I/ED). The peak energy of these plots is optimum in terms of the maximum
amount of scattered photons with the least amount of deposited energy. In other650
words, the x-ray utilization, U , which is the ratio of scattering intensity across all
angles of interest and the deposited energy in the object.
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Figure 3.6: Scatter profiles of analytic GNP monomer for energies 5 to 95 keV and






Figure 3.7: (a) This plot shows the number of scattered photons, I, between a q of
0 and 2 nm−1 over total number of photons simulated, H, as a function of the x-ray
energy for different sample thicknesses. (b) Plot of the energy deposited on sample,
ED, over H. (c) Plot of the utilization energy, U , which is I divided by ED. The
maximum U indicates the energy which produces the largest number of scattered




We qualitatively confirm there is little to no bias added to scatter profiles
from MC-GPU code because the simulated scatter profiles match the input scatter 655
profiles from analytic models as seen in Fig. 3.3. This demonstrates the software
can successfully simulate complete SAXS acquisitions in the computer.
Our findings show that simulations extended to the interaction fraction figure-
of-merit using analytically-derived cross sections produces very little error (<1.5%)
with respect to analytical models. The main source of error is primarily due to sub- 660
traction of a simulated noisy solvent. The comparison of the analytically-derived to
the empirically-derived cross sections allows us to validate the methodology. Dif-
ferences in the interaction fractions of the measured cross section and the expected
results (Fig. 3.5) are not due to errors in the measurement, but, on the contrary, due
to error in our estimated interaction fractions based on volumetric ratios of GNP 665
monomer and dimer solutions.
Simulations which varied energy and sample thickness corroborated our expec-
tations that scatter information detected is greatly reduced for thicker samples with
lower x-ray energies. For example, in Fig. 3.6, very little scatter information was
detected for x-ray energies below 20 keV for samples with 10 cm sample thickness, 670
however, using higher energy x rays could recover some of the scatter data within a
limited angular range.
Some SAXS applications require a short measurement time, in which case, the
optimal energy would be one that produces the most coherent scatter at the detector
44
in an angular range of interest regardless of dose. In Fig. 3.7, for sample thickness675
of 1 mm, simulations showed that 9 keV x rays produced the most coherent scatter
in the angular range of interest which agrees with design choices of many laboratory
SAXS systems that use Cu Kα x rays (around 8 keV) with 1 mm thick sample
holders.
For in vivo applications where dose minimization is desirable, the optimal680
energy is one that balances having more coherent scatter at the detector in an
angular range of interest and reduced energy deposited in the sample. This optimal
energy for in vivo applications is at the maximum utilization, Umax, where U is the
sum of scattered photons, I, over an angular range of interest divided by the energy
deposited in the sample, ED, for each energy, E. For our GNP sample in water685
with a thickness of 1 mm, energy at Umax was 31 keV. For the same sample with a
thickness of 10 cm, energy at Umax was 49 keV. Some caveats are the energy at Umax
depends on the cross section of the sample measured, the angular range of interest,
sample geometry, and instrument geometry. We show that simulations can be used
for SAXS system design optimization based on a particular sample and application.690
There are many benefits to using MC-GPU for simulations of SAXS. The sim-
ulated scatter profiles allow us to estimate contributions from Compton, Rayleigh,
and multiple-scattered and primary x rays. For additional realism, the ideal detec-
tor could be replaced with models of detectors by varying detection efficiency and
the x-ray pencil beam could be replaced with a cone beam with a variety of different695
collimation system designs. Simulations could be repeated for system variance es-
timations which may not be possible in experimental measurements due to changes
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in the sample over time and experimental error. In addition, user-provided cross
sections from empirical measurements of complicated biological materials could be
assigned to materials in virtual phantoms of small animals and human heads and 700
simulated with our code to investigate potential in vivo applications of SAXS [43,49].
3.5 Conclusion
We have utilized and validated MC-GPU to simulate x-ray transport in a full
SAXS system using empirical cross sections to describe x-ray interactions in virtual
samples. This method allows the investigation of factors that affect design choices 705
given thicker and more complex samples (i.e., the monochromatic x-ray energy,
and if safety is a concern, the amount of energy deposited in the sample). We
have shown that MC-GPU simulation of x-ray transport in SAXS could be used to
optimize instrumentation to produce the most scatter in an angular range given a
fixed primary number of x rays and estimate radiation energy deposited on a sample. 710
MC-GPU is open source and publicly distributed online for free. This work was
critical to enabling realistic simulations of SAXS imaging for medical applications
in the coming chapters.
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Chapter 4: MC Simulations of simplified SAXS-CT imaging system
We used a publicly available MC-GPU code to simulate x-ray trajectories715
in a SAXS-CT geometry for a target material embedded in a water background
material with varying sample sizes (1, 3, 5, and 10 mm). Our target materials
were water solution of gold nanoparticle (GNP) spheres with a radius of 6 nm and
a water solution with dissolved serum albumin (BSA) proteins due to their well-
characterized scatter profiles at small angles and highly scattering properties. The720
background material was water. Our objective is to study how the reconstructed
scatter profile degrades at larger target imaging depths and increasing sample sizes.
We have found that scatter profiles of the GNP in water can still be reconstructed
at depths up to 5 mm embedded at the center of a 10 mm sample. Scatter profiles
of BSA in water were also reconstructed at depths up to 5 mm in a 10 mm sample725
but with noticeable signal degradation as compared to the GNP sample. This work




Coherent scattering allows for detailed tissue characterization and added con- 730
trast compared to transmission x-ray and computed tomography (CT) imaging [46].
However, challenges remain for the technique to be used clinically. Among them,
measurement times must be reduced, microfocus x-ray sources must be further de-
veloped for smaller beam sizes and higher flux, and total radiation dose must be
estimated and possibly reduced. In this context, a methodology to measure the 735
limitations regarding sample depth of a SAXS imaging system has yet to be devel-
oped. When these challenges are met, small-angle x-ray scattering CT (SAXS-CT)
for in vivo imaging will represent a powerful diagnostic tool for a number diagnostic
applications. In this work, we present a preliminary description for a method to
study the sample size limit of SAXS-CT which depends on instrumentation design, 740
cross-section strength of the molecular targets and background materials.
4.2 Methods
We used a publicly available, GPU-accelerated, Monte Carlo tool (MC-GPU [9])
to simulate a large number of x-ray trajectories. MC-GPU has been used and val-
idated to generate clinically-realistic images and accurate radiation dose estimates 745
for a number of x-ray imaging modalities (radiography, computed tomography [10],
digital breast tomosynthesis [93]). The code was recently modified for a SAXS-CT
geometry with increased cross-section sampling at small scattering angles and to
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allow user-generated cross sections of particular materials to account for molecular
interference effects [19,28].750
Small-angle cross sections were obtained via experimental measurements or
online small-angle scatter databases and converted to an input material file for
MC-GPU. For our target material, we have used cross-sections of monomeric gold
nanoparticle (GNP) spheres with a radius of 6 nm as the target dissolved in water,
and bovine serum albumin (BSA), dissolved in water as shown in Fig. 4.1. The GNP755
samples were first measured and theoretical scatter curves of ideal spheres were fit
and scaled to the intensity of our measurements [6].
We obtained BSA measurements from the SAS biological database [88]. BSA
(ID: SASDA3) was measured using synchrotron radiation source in Hamburg, Ger-
many. The cross section of water is a known constant of 0.587 nm2 at small-angles760
between 0-12 nm−1. It is represented in the standard manner scaling SAXS mea-
surements to absolute values to obtain cross sections.
The geometry and location of the target material (GNP or BSA in water) is
depicted in Fig. 4.2(a) as the inner yellow cylinder. The cross section of water was
used for the background material depicted in Fig. 4.2(a) as the surrounding blue765
cylinder. We varied the depth of the target material by increasing the diameter
of the background material while keeping the target material diameter at 3 mm.
We used four sample geometries total: (1 and 2) control target material with no
surrounding background material, (3) target material within a 5 mm diameter back-
ground, and (4) target material within a 10 mm diameter background. The sample770
geometries used voxels of 0.005 mm x, 0.005 mm y, and 1 cm z (reference axis shown
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Figure 4.1: Theoretical cross-section models for GNP in water, BSA in water, and
water used in simulations.
in Fig. 4.2(b)).
The geometry of the simulated SAXS-CT instrument is shown in Fig. 4.2(b).
The x-ray source used was an infinitely small 8 keV monochromatic pencil beam
with a beam size of 0.01 cm at the center of each sample. The distance of the front 775
edge of the sample to the detector was fixed at 29 cm. d is the distance between
the center of the sample to the detector which varied little with the size of the three
samples.
The detector is shown in Fig. 4.2(c). The maximum radius of the detector was
1.4 cm. There were 40 radial pixels with 100% detection efficiency. These instrument 780
parameters achieve a scatter x-ray intensity profile with 40 points evenly in a q-range
of 0.05 and 2 nm−1 (q is the momentum transfer defined as, q = 4πsin(θ)/λ) which
is the angular range where the largest cross-section difference is found between our
gold nanoparticle (GNP) target and water background material.
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(a) The four sample geometries.
X-ray source









Figure 4.2: MC-GPU simulation geometries of (a) samples, (b) an idealized SAXS
instrument, and (c) a radial detector. In (a), we simulated four sample objects.
The inner yellow cylinder is the target material, and the blue outer cylinder is the
background material. In (b), the blue arrow indicates a horizontal beam translation
across the sample. The red arrow indicates a sample rotation to achieve multiple
angular projections for CT reconstruction. In (c), the detector is radially shaped to
count scattered x rays, I, at various angles equidistant to the center.
We simulated 5 × 107, 5 × 107, 2 × 108, 2 × 109 primary x rays per beam785
translation in the x-axis for the 1 mm, 3 mm, 5 mm, and 10 mm thick samples
respectively. After translating the beam across the diameter of the sample +1 mm
on each end, the sample was rotated 1◦ and the beam was translated across the
x-axis again. This was repeated for 360 projections to achieve a full rotation about
the sample. The simulation took 3 min for the smallest sample and 17 h for the790
largest sample using 5 NVIDIA GeForce GTX Titan GPUs in parallel.
The reconstruction of tomographic images from the 2D scatter profile was first
presented in detail elsewhere [29,30]. The profiles provide measures of coherent scat-
ter intensity I arriving at a particular detector element (ring of pixels), integrated
along the beam path. The measured pixel intensity (normalized to solid angle ∆Ω795
51
subtended by the detector element and the transmitted intensity at q = 0 nm−1, I0)













where n0(l) is the volumetric electron density at l position along the path through
the object, dΣ(l, q)/dΩ is the differential coherent scatter cross section per scat-
tering solid angle, and q is the momentum transfer. The line integral of S = 800
n0(l)dΣ(l, q)/dΩ, is formally equivalent to the line integral of the linear attenua-
tion coefficient in conventional CT. Therefore, an image is reconstructed for each
ring (scattering angle), resulting in a series of tomographic images corresponding
to the scatter intensity at a series of scatter angles. The intensity at each detector
angle was reconstructed to achieve a slice image using a filtered back projection 805
(MATLAB iradon function).
4.3 Results
Fig. 4.3 shows SAXS-CT measurements of water solution with GNPs as the
target material. The 1 mm and 3 mm diameter target material without background
material are shown in the first two rows. The third row is the 3 mm diameter sample 810
with a 5 mm diameter background of water. The fourth row is the 3 mm diameter
target with a 10 mm diameter background. The smaller sample size required less
number of translations. The first column is a slice image of the voxelized samples.
Regions of air with low density in the image are depicted as black, the background
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water material is gray, and the target GNP material is white. The second column815
is the attenuation CT image from the primary beam. Columns 3-42 are the scatter
CT images at increasing angles. Fig. 4.4 shows SAXS-CT measurements in the
same format as Fig. 4.3 but for a water solution with BSA. There is less contrast for
BSA in the scattered images than for GNP because BSA has a smaller cross-section
intensity than GNP.820
Fig. 4.5 shows the reconstructed scatter profiles for all target materials in each
sample geometry. The first column pixel maps in Figs. 4.3 and 4.4 were used to
average intensities of all pixels belonging to the target material only at each angle.
These averaged values were normalized by the area of the detector and the total
number of x-ray trajectories simulated. The scatter profile can be seen in Fig. 4.5(left825
and middle). In addition, Fig. 4.5(right) shows the ratio of the calculated radius of
gyration by Guinier analysis [35], Rs/R0, of the reconstructed scatter profiles over
the original cross section for both BSA and GNP. With larger samples, Rs, diverges
from R0 more so than for GNP.
4.4 Discussion830
Our MC-GPU simulations confirm that SAXS-CT provides increased contrast
compared to conventional CT not only for high-Z materials but also for proteins.
This increased target contrast was qualitatively worse for BSA over GNP targets
especially for larger sample sizes. However, our results suggest that significant
contrast can be recovered for sample sizes of up to 10 mm.835
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Averaging pixels belonging to a particular target assisted with reconstructing
an accurate scatter profile for the material. However, an alternative approach would
be to repeat the simulation many times and average each pixel value rather than a
region for applications where targets are small with respect to pixel size.
GNP scatter profiles were reconstructed accurately even for the largest sample 840
with a Rs/R0 larger than 0.95. For BSA, the scatter profile accuracy decreased at
5 mm and 10 mm sample sizes but were still above a Rs/R0 of 0.89. This indicates
that the coherent x-ray scatter could provide additional information to the primary
attenuation images that are indicative of the molecular structure of the material.
We plan to extend the study to use different protein targets and more complex 845
background materials while investigating optimal energies for monoenergetic and
spectral x-ray sources. In particular, we are interested in studying the advantageous
effect of using higher energy x rays with larger sample sizes on improving image
quality and radiation dose minimization.
4.5 Conclusion 850
SAXS-CT is an emerging diagnostic medical tool that can potentially be used
for in vivo x-ray molecular characterization of tissues. We have used MC-GPU sim-
ulations to study SAXS imaging for a gold nanoparticle (GNP) and serum albumen
(BSA) protein target in a water background which serves as an initial investigation
for performance at depths higher than those consistent with most optical techniques 855
for molecular characterization.
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A scatter profile of GNP target was resolved when the target was embedded at
the center of a background material with 10 mm diameter and accurate information
such as the radius of gyration could still be determined using the Guinier approxima-
tion. The system remains to be optimized to shorten measurements times, to allow860
for measurements of larger objects, and to minimize radiation dose. All of these
concerns must be addressed before SAXS-CT can be translated to small-animal
imaging and clinical use.
In summary, a publicly available MC-GPU code was used to simulate x-ray
trajectories in CT geometry and can be used to further study image quality and865
radiation dose delivered to the sample. We plan to quantify the scatter signal
loss with increasing sample sizes with a variety of different protein targets and
complex background materials while performing validation of our simulations with

























































































































































































































































































































































































































































































































































































































































































































Figure 4.5: (Left) Reconstructed SAXS profiles of GNP by averaging all pixel values
within the target of the sample for each angle. Intensities are normalized by the area
of the detector and by the total number of x-rays simulated. (Middle) Reconstructed
SAXS profiles of BSA by averaging all pixel values within the target of the sample
for each angle. (Right) The ratio of the calculated radius of gyration for each of the
reconstructed SAXS curves for both BSA and GNP, Rs, over the calculated radius
of gyration of the original cross section used for simulations, R0.
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Chapter 5: PSAXS phantom imaging studies870
Coherent small-angle x-ray scattering (SAXS) provides molecular and nanometer-
scale structural information. By capturing SAXS data at multiple locations across
a sample, we obtained planar images and observed improved contrast given by the
difference in the material scattering cross sections. We use phantoms made with
3D printing techniques, with tissue-mimicking plastic (PMMA), and with a highly-875
scattering reference material (AgBe), chosen because of their well characterized
scattering cross section to demonstrate and characterize planar imaging of a labo-
ratory SAXS system. We measure 1.07 and 2.14 nm−1 angular intensity maps for
AgBe, 9.5 nm−1 for PMMA, and 12.3 nm−1 for Veroclear. The planar SAXS im-
ages show material discrimination based on their cross section features. The image880
signal-to-noise ratio (SNR) of each q image was dependent on exposure time and
x-ray flux. We observed a lower SNR (91 ± 48) at q angles where no characteristic
peaks for either material exist. To improve the visualization of the acquired data by
utilizing all q-binned data, we describe a weighted-sum presentation method with
a priori knowledge of relevant cross sections to improve SNR (10,000 ± 6400) over885
the SNR from a single q-image at 1.07 nm−1 (1100 ± 620). In addition, we describe
planar SAXS imaging of a mouse brain slice showing differentiation of tissue types
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as compared to a conventional absorption-based x-ray imaging technique.
5.1 Introduction
When x ray quanta interact with matter they are transmitted, absorbed, or 890
scattered. Several techniques make use of x-ray deflections at small angles to mea-
sure coherently scattered radiation that provides nanometer-scale structural infor-
mation (0.1-100 nm) of the scattering material. These approaches are typically
known as small-angle x-ray scattering (SAXS). Conventional x-ray medical imaging
techniques have primarily focused on differentiating materials based on absorption 895
properties providing micrometer scale morphology or spatial information. However,
absorption-based approaches are limited in that many pathologies share similar at-
tenuation characteristics with normal surrounding tissues, especially during early
disease stages where change occurs at molecular and cellular levels. Many attempted
to bridge the two approaches in order to obtain nanometer scale structural infor- 900
mation coupled with micrometer scale spatial information with the ultimate goal of
improving image quality and diagnostics. In a typical transmission SAXS design, an
x-ray pencil beam traverses a sample and scattering patterns are recorded at small
angles on a 1D or 2D detector. One approach to measure both scales simultane-
ously is by utilizing stepper motors to position a sample at various locations in the 905
x-ray beam collecting SAXS data at each position. This information could be used
differentiate materials by their inherent scattering cross section.
2D scanning SAXS has been explored clinically for various ex vivo biopsy
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applications including bone, [63] breast, [27] brain, [70] and cardiac tissues. [13]
Albeit a slower measurement compared to a single-shot, full-field, x-ray absorption910
image, the collection of scattering information provides unique information valuable
for material classification. However, translating 2D scanning SAXS imaging into
clinical practice requires the development of characterization and calibration tools
to design and optimize these novel imaging modalities. A physical phantom with
known material properties and geometry can greatly assist in the study of the system915
parameters affecting resolution, contrast, noise, and overall image quality.
We report planar SAXS (PSAXS) imaging using a laboratory system for a
set of physical phantoms and for mouse brain tissue. We discuss factors affecting
image quality in PSAXS imaging, describe a method for effective visualization, and
compare material differentiation to x-ray absorption imaging.920
5.2 Methods
Fig. 6.1 depicts the laboratory PSAXS system used for measurements. We use
a laboratory SAXS system (SAXSpace, Anton Paar, Ashland, VA, USA). The in-
strument utilizes a sealed Cu-anode tube optimized for Kα radiation (λ = 0.154 nm).
The system was configured in point collimation mode with an accessible q range of925
0.01–20 nm−1 (q = 4πsinθ/λ). A pinhole aperture was achieved using blocks to ap-
proximately 200×200 µm. We utilized 3 stepper motors with 10 µm step resolution
within the instrument vacuum sample chamber to control horizontal and vertical
sample motion with respect to a stationary x-ray beam with a sample-to-detector
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distance (SDD) of 110 mm. The imaging detector is a CCD camera with a pixel 930
pitch of 24 µm in an array of 2084×2084 pixels coupled with a Gd2O2S:Tb phosphor
screen designed for 8-keV x rays.
8 keV









Figure 5.1: Schematic of the setup for planar SAXS imaging.]
Data was acquired and binned in the CCD in 8x8 pixels to allow for shorter
measurement times and reduced memory storage. We noted that the highest angular
resolution was not needed considering the characteristics of the scatter profiles of 935
the materials used. A beamstop was positioned 5 cm in front of the detector to
attenuate a portion of the primary beam of transmitted x rays preventing saturation
of the detector pixels. All portions of the beam path were enclosed in a vacuum-
sealed chamber at 350 mbar. The acquired 2D image of the scattering was corrected
to account for the flat detector among other standard corrections using SAXStreat 940
(Anton Paar, Ashland, VA, USA). Then, the data was radially averaged and reduced
to 1D scatter profiles.
Due to the large number of subsequent measurements required per scan, it
is impractical to measure a dark current prior to each measurement. A reasonable
compromise is to record a dark current measurement with the same exposure time 945
at the end of each set of scanning measurements. Dark current shift over the scan
time was accounted for by selecting an angular position with no signal (0 m−1s−1)
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and subtracting a uniform offset to bring that intensity to 0 m−1s−1.
Fig. 6.3 shows our dark current signal and the detector value at a q of 6 nm−1
for each SAXS measurement in a typical set of scans.950
A set of physical phantoms was designed in Inkscape using an encapsulated
postscript format for the FDA logo and an Arial font for UMD lettering, exported in
a drawing exchange format and then extruded using OpenSCAD to be 1 mm thick.
The phantom designs were 3D-printed using a proprietary plastic (VeroclearTM).
As a comparison to a well-known plastic often used as tissue-mimicking material for955
x-ray absorption-based imaging modalities, we also cut the FDA logo into a slab
of Polymethyl methacrylate (PMMA) using computer numerical controlled (CNC)
milling. Fig. 5.5 (Top) shows the virtual designs and photographs of the 3D-printed
Veroclear phantoms and the milled PMMA phantom. Because the 3D-printed mate-
rial needed a thin base support in the letters, we use a well design with dimensions960
3.00x1.50x0.11 cm for UMD and 4.0x2.5x0.11 cm for FDA. Well bottom thick-
ness was 0.01 cm. The thickness standard deviation for the 3D-printed phantoms
was ±0.02 mm as determined by a digital caliper. The FDA logo was cut into
a 0.123 cm-thick slab of PMMA. The resulting PMMA phantom had dimensions
7.00x4.60x0.12 cm. The standard deviation in the thickness was 0.036 mm. The965
dimensions were designed to be small enough to fit in our sample holder and allow
for the logo and lettering range to be covered by the range of motion by the stepper
motors with a resolution relevant for tissue imaging (<1 mm). The phantom cut
by the milling instrument was designed to be larger to ease the cutting process. We
filled the wells in the Veroclear phantoms with silver behenate (AgBe) powder and970
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Figure 5.2: (Top) Dark current (DC) measurement. Red vertical line indicates q
position at the lowest value. The peak at 1.1 nm−1 is due to a row of bad pixels.
(Bottom) Plot of detector values for all scatter measurements acquired at the angular
position indicated by the red line. At the beginning of scanning measurements, the
first few measurements increase the CCD values and stay relatively steady, or slowly
decline. Only one DC measurement is needed and the DC shift can be corrected
by subtracting a unique offset per each measurement. The noise is due to the

























Figure 5.3: Absolute coherent scatter cross sections of AgBe, Veroclear, and PMMA.
used ScotchTMtape to seal the open side. Holes were punctured into each indepen-
dent segment of the wells to let air escape and prevent air pockets when the sample
was under vacuum pressure. A similar procedure was performed for the PMMA
phantom with both sides sealed with Scotch tape.
AgBe, Veroclear, and PMMA were selected for this work because they were975
independently measured to absolute scale using a glassy carbon intensity calibrant.
[5] In addition, these materials have a well-characterized isotropic scattering cross
section and remain unaltered for days inside the vacuum. Finally, the materials of
choice demonstrate significant and reproducible material differentiation under SAXS
imaging. Fig. 5.3 shows the absolute scatter profiles of the three materials used in980
this work. The minimum measured q was 0.79 nm−1.
We measured the UMD Veroclear phantom with 0.25 mm x and y steps with
5-s exposure at each location. In total, the scanned region covering the UMD letter-
ing was 2.4x0.8 cm. The measurements took approximately 12 h. For these sets of
measurements only, SDD was fixed at 302 mm which resulted in a measured q-range985
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of 0.19–6 nm−1. All other measurements were obtained with a SDD of 110 mm
providing a wider q-range of 0.79–19 nm−1. Exposure time was increased to 10-s
for better signal quality. The FDA Veroclear phantom was measured with 0.5 mm
step sizes with a scanned region of 2.4×1.0cm. Total measurement time was ap-
proximately 3 h. The FDA PMMA phantom was measured with 0.5 mm step sizes 990
and a scanned region of 2.5×1.1cm. Total measurement time was approximately 5
h. In addition, we measured the bottom corner of the D in this phantom with a
higher step resolution of 0.25 mm. The scanned region was 0.7×0.5 cm and took
approximately 2.4 h.
Data from PSAXS data can be visualized presenting the individual intensity 995
map for all q angles. However, to improve the visualization of material differentia-
tion, we propose a method based on weighted averaging. We weight the intensity at
each q angle with the value of the corresponding cross section data of the material






where G is weighted-sum intensity map, and g(q) is the intensity map at each q bin.
We measured the signal-to-noise ratio (SNR) by selecting 3 regions-of-interest
(ROI) for locations with AgBe and support material. The mean and variance were
calculated for each ROI and SNR was estimated by SNR = µAgBe/σ
2
support. The
reported SNR is the mean and standard deviation of 3 estimates for each image. 1005
To compare this imaging modality to x-ray absorption techniques utilized in
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most conventional x-ray medical imaging applications, we imaged a few of the phan-
toms with a 30 kV spectrum running at 1.5 mA for a 2 s exposure. Fig. 5.5 (Bottom
left) shows the PMMA FDA phantom with AgBe inside the logo, the Veroclear FDA
phantom with no AgBe, and a PMMA UMD phantom with AgBe on tape removed1010
from the UMD Veroclear phantom and attached to a uniform region of PMMA at
top right which was imaged using x-ray absorption technique. The x-ray generator
was UltraBright Microfocus source (Oxford Instruments, Abingdon, Oxfordshire,
UK) with tungsten anode. The detector was FlashScan30, an amorphous silicon-
based indirect detector (DPiX, Colorado Springs, CO, USA) with 2304×3200 pixels1015
with a pitch of 125 µm and a thick CsI scintillator (650 µm). We collected and
averaged five images of each phantom after dark-current and flat-field corrections.
In addition, we scanned a 1 mm coronal slice of a wild-type mouse brain with
0.25 mm step resolution placed in a tissue sample holder (Anton Paar, Ashland,
VA, USA). The sample holder has x-ray transparent windows and allows the tissue1020
to remain at atmospheric pressure while in the beam path. The mouse brain was
prepared by fixing in paraformaldehyde, slicing using a vibratome to 1 mm, and
was stored in a phosphate buffered solution at 4◦C until measurements. No staining
was performed to this tissue. 448 positions were measured with 100-s exposures for
total of 15 h. An x-ray absorption image was also measured using the same system1025
and settings used to measure absorption images for the phantoms.
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5.3 Results
Results from PSAXS measurements are presented in Fig. 5.4. Intensity maps
for the Veroclear UMD phantom are shown in the first column of images. This
was the largest region measured at the highest spatial resolution. Measurements 1030
were performed in 4 separate sessions and dark current was corrected in each ses-
sion independently. Horizontal streaks appear due to the inaccuracies If the dark
current subtraction for each session. It was the only phantom measured with SDD
of 302 mm. The SDD was reduced to 110 mm to acquire a wider angular range
and observe intensity maps at PMMA and Veroclear’s characteristic peaks at 9.5 1035
and 12.3 nm−1 and the exposure time per position was increased to 10 s per mea-
surement for all other phantoms to increase signal quality. At q locations where
characteristic scattering peaks of AgBe is known to exist, 1.07 and 2.14 nm−1, the
AgBe material was the most intense signal in the image. For comparison, we also
present an intensity map at a q-angle where no characteristic peaks exist for either 1040
support or AgBe material at 1.5 nm−1. As expected, contrast between the two ma-
terials in each image are greatly reduced at this angle and would be further reduced
with smaller q resolution bins.
PMMA and Veroclear materials both have broad peaks in their scattering cross
section, shown in Fig. 5.3, however PMMA has a scattering maxima at 9.5 nm−1. 1045
At that angle, support material regions were the most intense for PMMA phantoms.
Similarly, at 12.3 nm−1 the Veroclear material was the most intense. Conversely,
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Figure 5.4: Four sets of planar SAXS measurements showing intensity maps at
various q angles of interest for the phantoms. Support material and spatial resolution
are listed at the top.
The last row of images are the weighted-sum visualization as described in
Eq. 5.1. With known cross sections of the target, data from each q-bin can be1050
preferentially weighted and summed to increase the signal quality and material
differentiation in a single presentation. In these images, we have weighted the q-
images for AgBe. This presentation mode greatly improves the presentation of low
signal measurements as in the Veroclear UMD phantom. The estimated SNR for
images in the 4th column of Fig. 5.4 which was 1100 ± 620, 91 ± 48, 522 ± 205, 1001055









Figure 5.5: (Top row) OpenSCAD visualization of the phantom geometries. The
first two were designs for the 3D printer with support material. The last was
used as a stencil for CNC milling. (Middle) Photograph of 3D-printed Veroclear
phantoms attached to sample holder and of the CNC-milled PMMA. UMD was
3.00x1.50x0.11 cm and FDA was 4.0x2.5x0.11 cm in size. The lettering and logo
regions dipped inward and had a thickness at the bottom of the well of 0.01 cm. (Bot-
tom right) Photograph of CNC-milled PMMA with dimensions 7.00x4.60x0.12 cm.
The FDA logo was cut all the way through.(Bottom) Photograph of the phantoms
imaged in absorption mode and absorption x-ray images of phantoms.
As a comparison to PSAXS imaging, Fig. 5.5 (Bottom right) shows absorption
images of the phantoms using a conventional transmission x-ray system. While this
method can show contrast in plastic thickness well, this imaging is not as clear for
material differentiation between AgBe and the PMMA in the phantom on the left. 1060
Moreover, material differentiation between Veroclear and PMMA is not possible.
Differentiation could be confirmed with additional scattering data from PSAXS
imaging. For areas with trace amounts of AgBe powder, as shown on the tape at












Figure 5.6: (Left) A. Photograph of coronal slice of wild-type mouse brain. B. Cor-
responding x-ray image after dark and flat field correction. C. Combined PSAXS
image summing all q angle images and dividing by number of q bins. (Right) Mon-
tage of PSAXS images of coronal slice from a wild-type mouse brain for first 63 q
bins. Color bar represents absolute scattering intensity (cm−1sr−1).
Finally, we present an application of PSAXS imaging to biological samples.
Fig. 5.6 shows tissue type differentiation for a 1 mm coronal slice of wild-type mouse
brain. The montage shows scatter intensity maps of the first 63 q bins. Each q bin
corresponds to 0.0179 nm−1 and the q range was 0.02 to 1.13 nm−1. The first 4
images are from behind the beam stop in the beam path. Therefore, brain regions1070
are less intense than regions with only sample holder windows. The 7th row of
images show the corpus callosum structure with a characteristic scattering peak at
approximately 0.8 nm−1.
5.4 Discussion
This work contributes to the study of factors affecting noise, artifacts, reso-1075
lution, contrast and signal in a PSAXS imaging system. Using well-characterized
materials at known locations in imaging phantoms, we can assess the influence of
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these effects on image quality. Factors that affect image noise in this modality are
associated with the detector used including its dark current stability and pixel non-
uniformity. We observed a CCD temperature-dependent, temporal shift in dark 1080
current intensity and how this can affect images as seen in the Veroclear UMD
phantom in Fig. 5.4. This could be improved by measuring a dark current between
each measurement, however for practical reasons in shortening total measurement
times, we measured only one dark current, and then performed a vertical offset for
each frame using a reference region in the scatter profile that is expected to be 1085
0 m−1 sr−1. In addition, we found cosmic rays appearing often in our measurements
which manifest as sharp uncharacteristic peaks at random q locations in the scatter
profile. Understanding the material cross sections measured could help filter these
spikes out of the data in post-processing steps along with the use of despiking cor-
rections. [12] Shot noise is affected by the exposure time and x-ray flux. Shot noise 1090
becomes more apparent in q images where not much scattering is measured due
to material characteristics. We found important that shot noise does not affect a
scatter image at a location where a characteristic peak is present. If shot noise is
observed at these images, one approach is to increase exposure time. Higher bril-
liance systems such as those existing at synchrotron (1011 - 1013 photons/second) 1095
can greatly reduce imaging times while maintaining good signal quality. In addition,
10 µm spatial resolution can currently be achieved at sychrotrons.
The non-uniform intensity in regions of the lettering and logo at AgBe peaks
could be attributed to a combination of the effect of varying AgBe densities and
of measurement fluctuations. The photographs in Fig. 5.5 were taken after mea- 1100
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surements. Visible differences in density of AgBe can be correlated to the PSAXS
images.
We have demonstrated PSAXS imaging in a laboratory commercial SAXS
system with a beam size of 200 µm and step sizes down to 250 µm. This laboratory
set-up could be useful in applications where the spatial resolution is utilized for1105
coarse registration of positions within a tissue sample, and the SAXS data at each
position provide structural changes happening at the molecular level.
In PSAXS imaging, spatial resolution is dictated by the step size of the object
holder, the beam size, and the beam divergence. Angular q resolution is affected by
the beam size and beam divergence as well as by the detector pixel size and pixel1110
binning.
5.5 Conclusion
This work demonstrates the capabilities of utilizing coherent scatter informa-
tion at small angles for medical imaging applications where precise material differen-
tiation of nanometer scale structures is needed. A phantom was constructed to show1115
logo and text patterns and imaged with a motorized sample holder for scanning. The
scatter cross section is an inherent characteristic of the material nanostructure and
can provide unique biomarkers for early detection of diseases. [16] Coherent scatter
image at small angles shows promise for imaging applications where contrast agents
or nonspecific molecular tags are undesirable.1120
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Chapter 6: PSAXS of mouse brains
In this chapter, we report results from planar SAXS imaging on sliced wild-type
mouse brains with characterization of gray and white matter and corpus callosum
cross section profiles. We describe methodology for measurement and data analysis
confirming characteristic peaks at 0.81 and 1.6 nm−1 for white matter and corpus 1125
callosum respectively. Accelerated Monte Carlo imaging simulations for a SAXS-CT
configuration are then performed with a simplified cylindrical model of the wild-type
mouse brain to demonstrate the capabilities of SAXS imaging. We simulated the
model with and without a skull material and found an average improvement in SNR
of 0.13 for all materials when a skull was not present. In addition, the dose deposited 1130
on the brain was calculated to be 2.4 Gy in the simulation performed with the skull,
and 2.2 Gy without the skull. Although the simulation without the skull had lower
overall estimated dose deposited, there was an increase of dose deposited on the
brain by 0.2 Gy. Our findings can be used to assess optimal instrument parameters
and for designing dedicated small-animal SAXS imaging prototypes. 1135
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6.1 Introduction
Small-angle x-ray scattering (SAXS) techniques measure coherently scattered
x-ray deflections at small angles analyzed to produce nanometer-scale structural in-
formation (0.1-100 nm) about the scattering sample. Recently, efforts have been
focused on utilizing SAXS for medical imaging to provide better material charac-1140
terization and for diagnostic applications. Since x rays carry higher energies than
visible light, SAXS imaging has potential to non-invasively image deeper tissues
beyond 1 mm.
Conventional x-ray medical imaging techniques have primarily focused on dif-
ferentiating materials based on absorption properties providing micrometer scale1145
morphology. However, absorption-based imaging approaches are limited in that
many pathologies share similar attenuation characteristics with normal surrounding
anatomy, especially during early disease stages where change occurs at the molecular
and cellular levels. There is increasing interest in measuring and utilizing scattered x
rays, traditionally considered noise in absorption-based approaches, for nanometer-1150
scale structural information coupled with micrometer scale spatial information with
the ultimate goal of improving image quality and diagnostic performance.
In transmission SAXS, an x-ray pencil beam traverses a sample and scatter-
ing patterns are recorded at small angles on a 1D or 2D detector. As shown in
Fig. 6.1(left) Planar SAXS (PSAXS) might use stepper motors to position and col-1155
lect SAXS data at various locations in the plane orthogonal to the beam direction.
This information could be used to map and differentiate materials by their inherent
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scattering cross section. Several research groups have investigated this approach
for studying nanostructure characterization of bone, [32, 63] and recently of car-
diac tissue. [13] However SAXS signal quality and resolution are affected by sample 1160
thickness and therefore applications of PSAXS have been limited to ex vivo biopsy
studies. To contribute to the improvement of these new modality, we have recently
reported on imaging phantoms for the assessment of PSAXS image quality. [17]
A different approach is depicted in Fig. 6.1(right). Here, a SAXS computed to-
mography (SAXS-CT) design uses image reconstruction algorithms to obtain SAXS 1165
profiles of locations deep within objects enabling applications in in vivo molecu-
lar x-ray imaging. This technique has been used to study biological tissues and
plastics, [39] polyethelene, [75] collagen-based phantoms, [91] lamb tissue, [52] and
rat brain tissue. [46, 47] We have recently explored a method to assess SAXS data

















Figure 6.1: Schematic of the imaging setup for planar SAXS (left) and SAXS-CT
(right).
One major area of interest in clinical applications of SAXS imaging is the
study and diagnosis of neurological disorders. There are currently no known cures
or effective treatment for many neurological disorders. Recent discoveries indicate
that biomolecular changes may appear 20 or more years before dementia symp-
76
toms appear. In this context, SAXS imaging may be able to detect earlier disease1175
changes and used to study therapy effectiveness. [16,84] The most notable potential
biomarker is myelin, a highly structured fibrous tissue that has been investigated
using SAXS for multiple sclerosis. [23,46,85] In addition, amyloid fibers [25,53] have
been investigated for imaging Alzheimer’s disease along with SAXS signals of brain
tumours. [81]1180
Other brain imaging methods include optical techniques that can successfully
characterize molecular neurological hallmarks but lack the ability to image deep
tissue where the hallmarks tend to form during early stages of disease. On the
other hand, PET imaging has become the standard of practice for in vivo imaging
using amyloid-targeting tracers. However, PET suffers from inherently low spatial1185
resolution and low specificity. [80] MRI techniques, on the other hand, have high
spatial resolution (up to microscale resolution). MRI is currently utilized to study
myelin density and location, [55, 83] but is not yet able to characterize nanoscale
structural information.
The brain has been studied in X-ray diffraction, SAXS, or WAXS studies over1190
the past 30 years. We provide here a summary of the work related to measured
scattering cross sections of brain tissue and report cross section peaks from these
studies in Table 6.1. Alzheimer’s disease studies using x-ray diffraction were first
attempted by Chia et al. [15] in 1984. They studied diffraction peaks of myelin iso-
lated from the white matter from human brain of 3 Alzheimer’s disease patients and1195
3 age-matched normal control patients. The study used a laboratory CuKα point
source collecting scatter on film for 4 h. They found broad peaks at 0.415, 0.46, and
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1 nm−1 for normal brain sections, and only the 0.46, and 1 nm−1 for Alzheimer’s
disease brain sections. In 2000, Lazarev et al. [54] studied x-ray diffraction patters
from fresh 1x5x8 mm samples of human brain white matter among other tissues 1200
with no chemical alterations or preservation. They used an 8 keV monochromatic
laboratory source with a 8x0.4 mm focal spot and an incident energy per mea-
surement of 2x108 photons in 10-mm beam length with an accessible q-range of
0.044–5.2 nm−1. They found diffraction peaks for normal brain, Alzheimer’s brain,
and cerebral hemorrhage at 0.3189, 0.8055, 1.28, and 1.65 nm−1, with the strongest 1205
peak at 0.8055 nm−1.
More recently, Avila et al. [7] studied x-ray diffraction patterns of transgenic
mouse optic and sciatic nerve surgically removed and isolated intact. They stretched
the nerve bundle within a quartz capillary and measured diffraction patterns with a
Cu Kα radiation. X-ray diffraction patterns were recorded for an hour using a linear, 1210
position-sensitive detector. The focal spot was 0.8 mm2. They compared results
of fixed, unfixed, and plastic embedded nerves on myelin periodicity. They found
aldehyde treatment introduced a 7% increase in myelin periodicity and a 5% decrease
in relative intensity as compared to unfixed nerves. The plastic embedded nerves
suppressed myelin peaks to <1% of relative myelin amount over myelin and the 1215
background compared to 25% and 30% for unfixed and fixed myelin respectively. The
theoretical periodicity of myelin was 17.4 nm which is associated with peaks every
0.36 nm−1. However in their measurements, they found myelin periodicity varied
depending on preservation technique between 18.7–20.1 nm ± 4 nm (using largest
error bar values), which is associated with peaks periodically occurring between 1220
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0.313–0.336 nm−1. The relative amount of myelin over myelin and the background
varied ± 10%. They also studied a isotonic and hypotonic buffer and how swelling of
the myelin affects periodicity measurements, provided a comparison for the sciatic
and optic nerve, and compared periodicity measurements for optic and sciatic nerves
from various transgenic mice. In 2008, De Felici et al. [23] studied the structure1225
of human cerebral myelin sheaths using a synchrotron source of intact white and
gray matter. The authors reported on the packing order of myelin and attributed
distances to SAXS profiles. To avoid measurements of structural changes due to
the preservative, they took special care to measure samples within a few days of
extraction from cadavers. They used 1 mm thick and 10 mm diameter brain samples1230
immersed in formaldehyde and a 12.4 keV with 50x50 µm2 focal spot. The CCD
detector covered a range of 0.036 to 0.49 and 4.7 to 48 nm−1 using two different
sample-to-detector distances. They randomly probed 20 locations in the sample in
the white or gray matter. All data showed isotropic rings. In the SAXS data, they
found characteristic peaks of white matter at 0.5, 0.75, 1.0, 1.1, 1.5, and 1.8 nm−1.1235
The gray matter had similar peaks, but to a much lower intensity. The white
matter WAXS data showed 3 broad peaks at 14.4, 20.1, and 29.0 nm−1. The gray
matter WAXS data had peaks at 20.1 and 29 nm−1 but none at 14.4 nm−1. They
also found that human myelin sheath has a periodicity of 16.5 nm with a slight
difference between male and female samples.1240
The first SAXS-CT study of an intact whole rat brain was performed by Jensen
et al. [46] using a high-brilliance synchrotron source (1011 photons/s) at 18.58 keV
and with a focal spot size of 25 µm2 using a photon counting PILATUS 2M detector.
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They reported measurements for a total of 541 projections over 360◦ each for 721
translation steps of 25 µm with 150 ms for scatter measurements and 10 ms for 1245
absorption measurements. One tomographic slice was obtained after an exposure
time of 24 h. They studied myelin sheaths of mouse brains and reported periodic
myelin sheath peaks at approximately 0.35, 0.7, 1.05, 1.35 nm−1. They also reported
cytoskeletal neurofilaments at 0.6 and 1.05 nm−1. They found the second neurofil-
ament peak to overlap with myelin’s third peak. The corpus callosum had higher 1250
intensity of myelin peaks because these structure consists of densely packed neurons
connecting the left and right hemisphere. These authors reported that myelin is the
most highly scattering isotropic signal from the brain in the measured range.
In this paper, we report and analyze SAXS cross sections of various brain
tissues. Our findings will stimulate the understanding of variability for various 1255
brain structures to be used in exploratory simulations to assess feasibility of in vivo
methods and in the design of optimized dedicated systems for small-animal imaging.
6.2 Methods
6.2.1 SAXS measurements
We use a laboratory SAXS system (SAXSpace, Anton Paar, Ashland, VA, 1260
USA) for PSAXS measurements (Fig. 6.1,left). The instrument utilizes a sealed Cu-
anode tube optimized for Kα radiation (λ= 0.154 nm). The system was configured in
point collimation mode with an accessible q range of 0.01–20 nm−1 (q = 4πsin(θ)/λ).
A pinhole aperture was achieved using blocks to approximately 200x200 µm. We
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5] 0.415 15.14 Myelin (WM) Human Brain: AD
0.460 13.65 Myelin (WM) Human Brain: AD, Normal









0.32 19.7 WM Human Brain: AD, Normal
0.81 7.80 WM Human Brain: AD, Normal
1.28 4.90 WM Human Brain: AD






] 0.32 17.4±1.2 Myelin Mouse nerve: fresh
0.41 15.3±1.0 Myelin Mouse optic nerve: fresh
0.34 18.7 Myelin Mouse nerve: fixed









0.375 16.75 WM Human brain
0.760 8.267 WM/GM Human brain
1.030 6.100 WM Human brain
1.140 5.511 WM Human brain
1.153 4.120 WM/GM Human brain
1.900 3.307 WM Human brain
14.40 0.436 WM Human brain
20.10 0.313 WM/GM Human brain







] 0.37 16.75 Myelin Rat brain
0.6 4.120 Neurofilament Rat brain
0.75 8.267 Myelin Rat brain
1.1 6.100 Myelin, Neurofilament Rat brain
1.4 5.511 Myelin Rat brain
Table 6.1: Compilation of characteristic peaks of the nervous system from various
sources. AD : Alzheimer’s disease, WM : White matter, GM : Gray matter. Values
were estimated from figures in the articles and error of measurements are shown
when reported from sources.
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Mouse Slice ∆x,∆y (mm) Exposure time (s) Binning q-range (nm−1)
1 1 0.50 60 4x4 0.14–18.4
2 0.25 100 4x4 0.16–7.03
3 0.25 300 8x8 0.53–18.3
2 1 0.25 300 4x4 0.13–7.09
Table 6.2: Experimental settings of all slices measured.
utilized 3 stepper motors with 10 µm step resolution within the instrument vacuum 1265
sample chamber to control horizontal and vertical sample motion with respect to a
stationary x-ray beam. The imaging detector is a CCD camera with a pixel pitch of
24 µm in an array of 2084×2084 pixels coupled with a Gd2O2S:Tb phosphor screen
designed for 8-keV x rays.
We scanned four approximately 1 mm thick, coronal slices of a wild-type mouse 1270
brain placed in a tissue sample holder (Anton Paar, Ashland, VA, USA). The sam-
ple holder has x-ray transparent windows and allows the tissue to remain at atmo-
spheric pressure while in the beam path. The mice brains were prepared by fixing
in paraformaldehyde, slicing using a vibratome to 1 mm, and was stored in a phos-
phate buffered solution at 4◦C until measurements. No staining was performed to 1275
this tissue. Table 6.2 lists the spatial steps sizes, exposure time, binning of the CCD
pixels, and the q range measured by adjustment of the sample-to-detector distances
for each brain slice measured. The anatomy of brain slices were estimated by asso-
ciating structures in the photograph images to an available Allen Developing Mouse
Brain Atlas. [56] 1280
Because registration of a particular brain tissue type is difficult once inside the
SAXS system, it was necessary to image the brain slice in a 2D scanning SAXS, so
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we could register a particular cross-section measurement to a location in the brain.
Photographs were taken of the brain slice before measurements. The tissue dehy-
drated over a few hours outside a buffer solution. We found that after a slice of1285
brain dries, it could be re-hydrated by storing in phosphate buffered solution for
a few hours. However to prevent temporal effects from the drying process affect-
















Figure 6.2: Block diagram of PSAXS data processing. The main four blocks are
Dark Current Correction, Transmission Correction, Background Subtraction, and
Absolute Sntensity Scaling.
A beamstop was positioned 5 cm in front of the detector to attenuate a portion1290
of the primary beam of transmitted x rays preventing saturation of the detector
pixels. All portions of the beam path were enclosed in a vacuum-sealed chamber at
below 34 mbar. The acquired 2D image of the scattering was corrected to account
for standard geometric corrections due to instrument geometry and the CCD using
SAXStreat (Anton Paar, Ashland, VA, USA). Then, the data was radially averaged1295
and reduced to 1D scatter profiles, I(q). We performed four additional important
corrections for our data at each coordinate pixel position (x, y) as shown in Fig. 6.2.
The following describes each processing step.
83
6.2.2 Data Analysis
For each set of measurements, a dark current measurement was acquired for 1300
the same exposure as each position. Ideally, a dark current measurement would
be obtained immediately after each measurement to have the most accurate dark
current correction due to temporal effects. However, due to the large number of
subsequent measurements required per scan, it is impractical to measure a dark
current between each measurement. Because the shape of the dark current 1D curve 1305
does not change other than a temperature and time-dependent offset, a reasonable
compromise is to record a dark current measurement with the same exposure time at
the end of each set of scanning measurements. Dark current shift over the scan time
was accounted for by selecting an angular position with no signal (0 m−1 s−1) and
subtracting a time-dependent offset to bring that intensity to 0 m−1 s−1. Fig. 6.3 1310
shows our dark current signal and the detector value at a q of 6 nm−1 for each SAXS
measurement in a typical set of scans. The following equation shows the subtraction
of the dark current signal and an offset,
I
′
x,y = Ix,y(q)−Dc(q)− offsetx,y. (6.1)
Each position had the same exposure time, but there were slight variations in
thickness in the slice especially after drying. We corrected for thickness differences 1315
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Figure 6.3: (Top left) Dark current (DC) measurement. (Bottom left) Plot of de-
tector values after dark current subraction at a few angular positions for all scatter
measurements. The black line is an average of 30 angular positions. (Top right) All
measurements plotted by q after dark current subtraction, but before dark current
offset correction. (Bottom right) All measurements plotted by q after dark current
subtraction, and after dark current offset correction.









However, we make the assumption is that the tissue at each location has
approximately the same attenuation properties.
When scatter profiles at each location are corrected for dark current and trans-
mission differences, the background can be subtracted. We define the background1320
as the windows of the tissue sample holder that contribute to the scatter signal
measured. In the planar scan, we ensured that there are locations measured that
only contain the windows and no tissue. We averaged the scatter profile of all pixels










To convert empirical measurements to absolute cross sections, measurements
of a secondary intensity standard, 1 mm thick glassy carbon, [94] and q calibration
reference [14], silver behenate (AgBe), were also acquired in the same scan. The
glassy carbon measurements were scaled to NIST data of absolute glassy carbon val-
ues and a calibration factor, Cf was obtained. The calibration factor was multiplied 1330






The q-angles in measurements were corrected by the AgBe measurements
where peak locations are known.
6.2.3 SAXS-CT simulations
To study SAXS-CT feasibility for brain imaging applications, simulations of 1335
x-ray transport of the entire SAXS imaging chain were performed using Monte Carlo
techniques. We used MC-GPU, a GPU-accelerated x-ray transport simulation tool
that has previously been used to generate clinically-realistic radiographic projection
images and computed tomography (CT) scans of the human anatomy. [9] The code is
publicly available and distributed for free in source form. MC-GPU massively multi- 1340
threads a Monte Carlo simulation algorithm for the transport of x rays in a voxelized
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geometry utilizing x-ray interaction models and cross sections from PENELOPE
2006. [73] MC-GPU has handled realistic human anatomy phantoms, like the freely
available Virtual Family model, [20] and adapted to simulate coherent scattering CT
incorporating molecular form factor and structure factor effects. [18,19,28] The x-ray1345
source is an infinitely small monochromatic pinhole beam which can be set to a single
monochromatic energy or spectra. The detector pixels 100% detection efficiency and
can be set to any size with any resolution. The input text file specifies instrument
geometry including detector size, source-to-detector distance, sample-to-detector
distance, monochromatic energy of the source and other important parameters for1350
the simulation such as the number of x-ray tracks to simulate, number of GPUs to
use in multithreading process. The voxelized sample geometry is defined in a text
file which specifies number of voxels, material assignment, and density of material
(g/cm3).
The molecular form factors can be obtained by measuring the scattering profile.1355
The process is demonstrated in detail elsewhere [8, 50, 87], here we will give a brief
description. The measured scatter profile provide relative values of (1+cos2(θ/2))×
F 2Mol(q) that are not readily usable in the simulation code. It is known for theoretical
considerations [8, 38] that at sufficiently large momentum transfer q the measured






where ni is the weight fraction of element i, Z is the atomic number, F (q, Z) is
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the coherent scatter form factor for element i [42]. As a result, the absolute values
of F 2Mol(x) could be estimated by re-normalizing the data to fit the IAA values in
an interval of q ranging from 40 to 50 nm−1. In this study, we used our measured 1365
1D scatter profiles I(q) of white matter (WM1), gray matter (GM1) and skull form
factors estimation. We used the measured scatter profiles given by De Felici et
al. [23] for WM2 and GM2 for comparison.
For WM1 and GM1 we used the same form factors of WM2 and GM2 respec-
tively at wide angular range from 2.5–50 nm−1. For the skull we normalized our 1370
measured Fmol (given in relative values) to those given by Tartari et al. [87] for bone
in an interval of q ranging from 2.5 to 5 nm−1. A comparison of the form factors
obtained by IAA model and measured data are shown in fig.6.4 Fig. 6.4(a) shows
the geometry of the cylindrical model of the mouse head. The skull thickness was
0.2 mm, gray matter was 1 mm, and white matter was 8 mm in diameter. The 1375
density use for gray and white matter materials was 1.03 g/cm3 and the skull was
1.85 g/cm3. We simulated 100 translation points at 0.1 mm step sizes across this
1x1 cm2 region, 360 projections with 1◦ angular steps. The x-ray energy was 20 keV
monochromatic with a beam divergences 0.08◦. The sample-to-detector distance
was 30 cm. The detector was 3 cm in radius and had 300 bins from the center to 1380
edge with a q range of 0–10 nm−1. For each translation and projection, we simu-
lated 1×109 histories totalling 3.6×1013 histories for the CT slice image. This took
approximately 13 hours on a computer with 6 GeForce GTX Titan GPUs. To study
the effect of the skull on signal quality and dose deposited to the brain, we repeated
simulations replacing the skull material with WM1. 1385
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WM 1 WM 2
GM 1 GM 2
Skull
Air
(a) Virtual phantom of mouse brain
q [nm-1]



















WM and GM IAA
Skull IAA
(b) Form factor of materials.
Figure 6.4: (a) Simplified cylindrical model of a slice of a mouse head. (b) Coherent
scattering form factor for WM1, WM2, GM1, GM2 and skull materials. dotted line:
form factors calculated with IAA. Solid line: form factors measured in this study.
We calculated the signal-to-noise ratio (SNR) by taking the mean over the
standard deviation of pixel values belonging to each material,
SNR = µmat/σmat. (6.6)
This calculation could be achieved for each q intensity map, however, for the com-
parison of simulations with a skull in place versus skull replaced by gray matter, we
selected a q angle with a prominent peak for both WM1 and WM2 at 1.03 nm−1.1390
6.3 Results
Fig. 6.5 shows results from the first coronal slice in the frontal lobe of a wild-
type mouse brain. A photograph of the frontal section of the brain shows the left and
right hemisphere of the cortex in the upper two quadrants and the olfactory bulbs
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in the bottom two quadrants. Before measurement, the brain had dried in the tissue 1395
sample holder and in the process of drying, the two hemispheres had separated. We
present a q intensity map at 0.19 nm−1 where regions could be by intensity in the
pixels. The scatter profiles for each region were averaged. In this measurement,
since we measured with a SAXS and WAXS range, we stitched the scatter profiles
using the regions of overlap. There are two visible broad peaks at approximately 1 1400
and 1.6 nm−1 for region 1 that exists to a lesser degree for region 2. There is also a
very broad and low intensity peak at approximately 13.8 nm−1 which exists for both
regions. This particular slice had both gray and white matter superimposed in the
beampath, therefore there are influences of scattering from both tissue types in the
scatter profile. For this reason, the two peaks at small-angles may be suppressed. 1405
For the next set of measurements, we increased the exposure time to 100 s
for higher quality signal and observed only the SAXS range. Fig. 6.6 shows results
from a second slice from the wild-type mouse brain which has distinct gray matter
at the perimeter of the cortex, and a corpus callosum which can be seen as the
lighter white strand connecting the left and right hemispheres. At a particular q of 1410
0.81 nm−1, the intensity map shows a distinct structure of corpus callosum which
is more intense with respect to the other parts of the brain. Two regions were : A
structure that is likely to be the corpus callosum, and the remaining region of the
brain. The average scatter profile of pixels in the region shows there is a distinct
peak at 0.81 and 1.62 nm−1 that is more intense in the corpus callosum region of 1415
the slice.
































Figure 6.5: (A.) Photograph of first coronal slice into the frontal lobe of the wild-
type mouse brain. The upper half is the cortex, whereas the bottom half are the
olfactory bulbs. (B.) An intensity map at q=0.19 nm−1. (C.) First region where
intensity was higher than 5 cm−1 sr−1 in B. (D.) Second region where the intensity
was between 0.6 and 5 cm−1 sr−1 in B. (Bottom) Stitched data of the average frontal
lobe using measurements in SAXS and WAXS range. The scatter profiles are a result
of the average of pixels in the two regions depicted in C and D. Error bars are ±1σ
for every 10 points.
set with an exposure time of 300 s per position and observed the WAXS range.
Fig. 6.7 shows results from a third slice from the mouse. During the drying process,
the brain slice had curled at the edges. We observed the intensity map at a strong1420
peak of q=1.6 nm−1 and three regions by intensity. The average scatter profiles of
pixels in the regions shows there is a distinct peak at 0.92 and 1.6 nm−1 to varying
intensities. The q resolution for these measurements were also lower due to binning
by 8x8 instead of 4x4 in other measurements. The higher binning allowed for higher
signal at wider angles where broad peaks occur and where high angular resolution1425
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Figure 6.6: (A.) Photograph of a coronal slice in a wild-type mouse brain. (B.) An
intensity map at q=0.81 nm−1. (C.) First region where intensity was higher than
1 cm−1 sr−1 in B. (D.) Second region where the intensity was between 0.2 and 1
cm−1 sr−1 in B. (Bottom) Scatter profiles of the average of pixels in the two regions
depicted in C and D. Error bars are ±1σ for every 10 points.
is not needed. There is a broad peak at 7.14 and another at 14.6 nm−1.
Finally, we present measurements of a slice from a second wild-type mouse
brain with an exposure time of 300 s per position and observed the SAXS range
in Fig. 6.8. The first peak existed for all positions at q=1.01 nm−1, so we three
regions by the intensity map at that angle. The average scatter profiles of pixels 1430
in the regions shows there are two distinct peaks at 1.01 and 1.53 nm−1 also to
varying intensities. All observed peaks, both distinct and subtle, in scatter profiles
measured were tabulated in Table 6.3.
Fig. 6.9 shows SAXS-CT simulations of a simplified mouse head constructed
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Figure 6.7: (A.) Photograph of a coronal slice in a wild-type mouse brain. (B.) An
intensity map at q=01.6 nm−1. (C.) First region where intensity was higher than
0.5 cm−1 sr−1 in B. (D.) Second region where the intensity was between 0.35 and
0.5 cm−1 sr−1 in B. (E.) Third region where the intensity was between 0.2 and 0.35
cm−1 sr−1 in B.(Bottom) Scatter profiles of the average of pixels in the three regions
depicted in C,D and E. Error bars are ±1σ for every 10 points.
of cylinders. The outer layer is bone with a thickness of 0.2 mm. The next layer1435
is gray matter with a thickness of 1 mm. The inner layer is white matter with a
thickness of 8 mm. Also in Fig. 6.9, we show material cross sections obtained from
literature, whereas the right side uses material cross sections we measured. The
CT images show at particular angles, the white matter material has more contrast
with respect to other materials. By averaging the pixels belonging to each material1440
type, we can reconstruct the scattering x-ray cross section of the materials. Because
the skull is expected to be highly attenuating, we also simulated the same virtual
phantom but with the skull voxels replaced with GM2 which is shown in the middle
figure. All SAXS-CT images show presence of the skull. The simulation with the
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Figure 6.8: (A.) Photograph of a coronal slice in a second wild-type mouse brain.
Dotted yellow line indicates region that was imaged. (B.) An intensity map at
q=1.01 nm−1 where the first peak appeared in the scatter profiles. (C.) First region
where intensity was higher than 0.7 cm−1 sr−1 in B. (D.) Second region where the
intensity was between 0.3 and 0.7 cm−1 sr−1 in B. (E.) Third region where the
intensity was between 0.1 and 0.3 cm−1 sr−1 in B.(Bottom) Scatter profiles of the
average of pixels in the three regions depicted in C,D and E. Error bars are ±1σ for
every 10 points.
skull calculated an estimated total dose of 2.4 Gy whereas the simulation without 1445
the skull was 2.2 Gy deposited on the entire region imaged. In the simulation with
the skull, the white and gray matter had each approximately 50 Gy whereas the
skull had 323 Gy, given density of the skull was 1.85 g/cm2 and at the perimeter of
the phantom whereas the brain density was 1.03 g/cm2 and at the center. In the
simulation without the skull, all materials were approximately between 50–57 Gy 1450
with a slight increase in dose deposited compared to simulations with the skull.
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Fig. 6.5 Fig. 6.6
q (nm−1) 1.60 14.1 0.39 0.56 0.81 1.01 1.58 1.92
d (nm) 3.93 0.45 16.1 13.7 7.76 6.22 3.98 3.27
Fig. 6.7 Fig. 6.8
q (nm−1) 0.96 1.65 2.48 3.01 3.89 6.75 15.4 0.55 0.66 0.82 1.01 1.53
d (nm) 6.55 3.81 2.53 1.62 1.61 0.93 0.41 11.4 9.52 7.66 6.22 4.11
Table 6.3: Compilation of characteristic peaks measured.
The calculated SNR for each material is tabulated below in Table. 6.4.
WM1 WM2 GM1 GM2
with skull 24.0 20.93 10.8 6.30
without skull 24.9 21.3 10.0 6.20
Table 6.4: SNR of each material for simulations with or without a skull present.
6.4 Discussion
We measured approximately 1 mm thick slices of wild-type mouse brain with
an aim of characterizing the small-angle scattering cross section for various tissue1455
types and compare to results from others. A planar SAXS set-up allowed us to
register different parts of the brain to SAXS intensity maps. Our planar SAXS
measurements of three slices of normal wild-type mouse brain show regions in the
slice of the brain with common characteristic cross section features, in particular,
with the corpus callosum.1460
Some sources of error in our measurements are due to imperfect dark current
subtraction since only one is obtained at the end. We mitigated some of the error
by offsetting by a constant that is determined by averaging several points near the
tail-end of the scatter profile that is supposed to be approximately 0 cm−1 sr−1.
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This reduced the standard deviation across all measurements at a few angles with 1465
approximately 0 cm−1 sr−1 in the scatter profile from 1.4201 to 0.1987 cm−1 sr−1 as
shown in Fig. 6.3 (right).
We scaled the intensity of the measurements to absolute scale using a secondary
glassy carbon standard, however, some error in absolute intensities are introduced
with imperfect background subtraction. In a conventional SAXS measurement of 1470
bio-molecules in solution, it is advised to use the same quartz capillary sample
holder for the signal measurement as well as the background measurement so the
sample holder can be subtracted more accurately. In a planar SAXS imaging, it
would be more robust to measure the same tissue sample holder without the tissue
as a location-dependent background measurement, however this would double the 1475
measurement time. As another compromise for our background subtraction, we
regions of windows of the tissue sample holder which served as the background signal
using intensity thresholds, averaged the scatter profile and used this as a surrogate
background for background subtraction. Negative intensities do not theoretically
exist in absolute x-ray scattering cross sections, however, they appear in our data 1480
in Fig. 6.5 and are an inevitable result of imperfect subtraction of noisy data.
Despite these errors, we were able to detect prominent peaks that exist in
white matter and more so in the corpus callosum structure which we suspect could
be due to the higher density of nerve fibers and myelin sheaths surrounding the
nerve axons. Myelin has been reported to be a strong small-angle scatterer and the 1485
subject of many neurological SAXS studies Our prominent peak was at 0.81 nm−1
which match with results from Lazarev et al., and are similar to 0.76 nm−1 from
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De Felici et al., and 0.75 nm−1 from Jensen et al. (refer to Table 6.1). The differ-
ences can be explained by the q resolution and uncertainty of our system, [65] but
also to differences in myelin and neuron structure in different species of animals as1490
previous reports were on the human and rat brain. Finally, the drying of the brain
before measurements may shrink the periodic packaging of the myelin layers thereby
overestimating the peak location.
Other peaks reported be others were not detected in our measurements. This is
probably because of a combination of low scatter signal intensities, peak broadening1495
due to our q resolution. Finer quality measurements can almost always be performed
at a synchrotron source where pencil beam sizes can go down to 10 µm2, there is
flexibility in energy of x-rays, and flux of the beam is between 1011 to 1013 photons/s.
However, we have demonstrated detection of the strongest myelin peak within the
corpus callosum structure with a laboratory source.1500
The SAXS-CT simulations showed that the approximate dose to an animal
for a single CT slice imaged was approximately 2.4 Gy. Improvements can be made
by using a higher energy at the sacrifice of the signal quality. At the settings we
used, we were successfully able to reconstruct the original cross sections of each pixel
location in the CT slice.1505
6.5 Conclusion
We have measured small-angle x-ray scattering (SAXS) of wild-type mouse
brain slices in a planar imaging mode to characterize cross sections of various tissue
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types within the brain. Our work compares results from wild-type mouse brain to
previous SAXS measurements of brains from other species and aims to generalize 1510
commonalities in cross section peaks attributed to myelin, which is the strongest
scatterer within the brain. We demonstrate SAXS-CT with simulations using a
Monte Carlo X-ray transport simulator (MC-GPU) of a simplified mouse head model
and report estimated SNR and radiation dose deposited to a brain for a CT slice.
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q (nm-1)
Slice Att 0.78237 1.0313 1.2091 7.4531
(a) SAXS-CT results of phantom with skull.
q (nm-1)
Slice Att 0.78237 1.0313 1.2091 7.4531
(b) SAXS-CT results of phantom without skull.
q (nm!1)















































Figure 6.9: (a) Results from SAXS-CT simulations using MC-GPU. First image
is a map of materials (same as Fig. 6.4(a)). The second image is the attenuation
image that a typical CT image would produce. The 3rd to 6th images are intensity
maps reconstructed from a specific q angle indicated below the image. (b) Results
of SAXS-CT simulations with the skull replaced by GM2. (c-d) Using the material
map in the first image, we averaged pixels belonging to a particular material and
plot cross sections of each material(c: with skull, d: without skull).
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Chapter 7: SAXS imaging of amyloids 1515
7.1 Introduction
Alzheimer’s disease (AD) remains the only disease in the top ten leading causes
of death in America that cannot be prevented, slowed, or reversed. [3] AD is the
most common degenerative brain disorder that destroys memory, thinking skills, and
ability for people to perform every day tasks. Precise biomolecular changes that lead 1520
to AD, why disease progression varies greatly among people, disease prevention, and
effective treatments are still unknown. [45,71,89]
One widely-accepted hypothesis posits that β amyloid deposition in the brain
parenchyma is a molecular culprit for AD onset and has been the target of AD
imaging and disease-modifying therapeutic research. [76] Some imaging methods to 1525
assess molecular changes in the brain include optical techniques that can success-
fully characterize neurological hallmarks but lack the ability to image deep tissue
(> 1 mm) where they tend to form during early stages of disease. On the other
hand, PET imaging has become the gold standard for in vivo imaging of amyloid
in the brain using amyloid-targeting tracers. However, PET suffers inherently from 1530
low spatial resolution and low specificity. [80] MRI techniques, on the other hand,
have high spatial resolution (up to microscale resolution). MRI is currently utilized
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to study myelin density and location, but are not yet able to achieve nanoscale
structural information. We propose that small-angle x-ray scattering (SAXS) imag-
ing may have the potential to detect β amyloid plaque earlier by their molecular1535
structure characteristics without tracers and assist in the need for better diagnostics
and therapy monitoring tools. [16]
SAXS is a biophysical method to study shape and structure of macromolecules
in solution. In transmission SAXS, a monoenergetic x-ray pencil beam traverses a
sample and scattering patterns are recorded at small angles on a 1D or 2D detec-1540
tor. Information on size, shape, and structure can be extracted from the recorded
scatter profiles through various analytical techniques. This technique has been used
extensively to study in vitro structure of β amyloid monomers, oligomers, and fibrils
in solution. [44,51,77]
SAXS has recently been extended to imaging applications is solids and soft1545
matter. Planar SAXS (PSAXS) uses stepper motors to position and collect SAXS
data at various locations in the sample in the plane orthogonal to the beam direction.
This information could be used to map and differentiate materials by their inherent
scattering cross section. Several research groups have investigated this approach for
studying nanostructure characterization of biological materials. [13, 32,63]1550
We histologically assess amyloid in an AD model mouse brain, measure and
compare PSAXS imaging of a coronal slice from transgenic AD model mouse brains
to a wild-type mouse brain, measure and report PSAXS measurements of a wild-
type mouse brain with a bovine serum albumin (BSA) amyloid fibril model placed at
a specific location and locate it using planar SAXS imaging, and simulate anthropo-1555
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morphic virtual phantoms of a mouse and human head with embedded neurological
plaque targets.
7.2 Methods
For PSAXS imaging measurements, a laboratory SAXS system (SAXSpace,
Anton Paar, Ashland, VA, USA) with a sealed Cu-anode tube optimized for Kα 1560
radiation (λ = 0.154 nm) was utilized. We configured the system in point collimation
mode with an accessible q range of 0.01–20 nm−1 (q = 4πsin(θ)/λ). The pinhole
aperture was approximately 200x200 µm. The system has 3 stepper motors with
10 µm step resolution to control sample position with respect to the beam within
air-tight vacuumed sample chamber. Scattered x-rays were captured by a CCD 1565
camera with a pixel pitch of 24 µm in an array of 2084×2084 pixels binned 4x4
coupled with a Gd2O2S:Tb phosphor screen designed for 8-keV x rays.
We obtained 2 wild-type (WT) 9 month old mouse brains along with 2 trans-
genic (Tg) AD model mouse brains that were 8 month old and 4 month old. The
mouse brains were prepared by fixing in paraformaldehyde, slicing coronally using 1570
a vibratome to 1 mm, and was stored in a phosphate buffered solution at 4◦C until
measurements with no staining performed. To confirm locations of amyloid deposits
in the AD mouse model, we took subsequent slices of the 1 mm thick slices at 40 µm
for histological confirmation using a amyloid-targeting dye, Thioflavin S. The 40 µm
slices were stained following procedures outlined by Rajamohamedsait et al. [69] For 1575
PSAXS measurements, we placed the 1 mm brain slices in a tissue sample holder
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(Anton Paar, Ashland, VA, USA). The sample holder utilizes x-ray transparent
windows and enables the tissue to remain at atmospheric pressure while in the vac-
uumed beam path. The SAXS signals of the slice was measured at 0.25 mm steps
horizontally and vertically to cover the entire region of the brain slice. Exposure1580
time was 300 s per position. The sample-to-detector distance was 30.5 cm to cover
a q range of 0.16 to 7 nm−1. 957 positions were measured and took 60.5 hours for
each slice.
We also measured a bovine serum albumin (BSA) amyloid fibril model placed
at a specific location in a wild-type mouse brain slice and locate it using planar1585
SAXS imaging. BSA fibrils mimic nanostructural qualities of amyloid fibrils by
their beta-sheet formation of threads. [22] BSA amyloid fibrils were concocted with
heating and cooling cycles of BSA in solution following work presented in Dahal et
al. [22] The first fibrils are formed within two weeks of initial preparation, however do
not continue growing after two months at room-temperature controlled incubation.1590
We waited two months for stability and saw visible white threads of BSA fibrils in
the solution. To condense the fibrils, we centrifuged the fibrils at 12,500 rpm for
30 minutes. A BSA fibril pellet was formed of diameter 0.8 mm. At measurement
time, the prepared BSA pellet was placed in the right side of the mouse brain slice
shown in Fig. 7.8. The photograph was taken after measurements where the tissue1595
was dehydrated. We found the tissue could be re-hydrated by storing in phosphate
buffered solution for a few hours. However we intentionally allowed the tissue to dry
before measurements to prevent temporal effects from the drying process affecting
measurements.
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To study SAXS-CT feasibility for in vivo brain imaging applications in mouse 1600
and human, simulations of x-ray transport of the entire SAXS imaging chain were
performed using Monte Carlo techniques. We used MC-GPU, a GPU-accelerated
x-ray transport simulation tool that has previously been used to generate clinically-
realistic radiographic projection images and computed tomography (CT) scans of
the human anatomy. [9] The code is publicly available and distributed for free in 1605
source form. MC-GPU massively multi-threads a Monte Carlo simulation algorithm
for the transport of x rays in a voxelized geometry utilizing x-ray interaction mod-
els and cross sections from PENELOPE 2006 [73] and was adapted to simulate
coherent scattering CT incorporating molecular form factor and structure factor
effects. [18, 19, 28] The x-ray source is an infinitely small monochromatic pinhole 1610
beam which can be set to a single monochromatic energy or spectra. The detector
pixels 100% detection efficiency and can be set to any size with any resolution. The
voxelized sample geometry is defined in a text file which specifies number of voxels,
material assignment, and density of material (g/cm3). We obtained voxelized virtual
phantom of a mouse from Digimouse, [86] with segmented regions using PET, CT, 1615
and crysosection data. Digimouse has a 0.1 mm3 voxel size and approximate size
of the head was 1.5 x 1.5 cm coronally. A voxelied human head phantom was ob-
tained from Iacono et al. [43] which segmented material regions by MRI data. This
phantom is called Multimodal Imaging-Based Detailed Anatomical Model (MIDA)
and has 0.05 mm3 voxel sizes. The approximate size of the MIDA phantom was 16 1620
x 20 cm transversly. For simulations in this work, we obtained a coronal slice in the
Digimouse head region and a transverse slice in the MIDA phantom.
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# Material Density (g/cm3)
0 Air 0.001 MIF
1 Skin 1.10 IAA
2 Skeleton 1.85 MIF
7 Gray Matter 1.03 MIF
8 Striatum 1.03 MIF
10 White Matter 1.03 MIF
11 Muscle 1.04 IAA
Table 7.1: Digimouse material index, materials, and density information in a sin-
gle coronal slice. MIF is material interference function which indicates we supplied
empirical scatter profiles at small angles. IAA is the independent atomic approxi-
mation, where theoretical scatter off of independent atoms are used in simulations
without consideration of interference effects.
# Material Density (g/cm3)
1 Air 0.001 MIF
2 Gray Matter 1.03 MIF
3 White Matter 1.03 MIF
4 Muscle 1.04 IAA
5 Adipose 0.92 IAA
6 Cortical Bone 1.85 MIF
7 Spongiosa Bone 1.85 MIF
8 Cartilage 1.85 MIF
9 Skin 1.10 IAA
10 Cerebrospinal Fluid 1.00 MIF
11 Blood 1.00 MIF
Table 7.2: MIDA material index, materials, and density information in a single
transverse slice. MIF is material interference function which indicates we supplied
empirical scatter profiles at small angles. IAA is the independent atomic approxi-
mation, where theoretical scatter off of independent atoms are used in simulations






Figure 7.1: (A.) Mesh 3D representation of the Digimouse virtual phantom and
approximate location of coronal slice used for SAXS-CT simulations. (B.) A coro-
nal slice through the voxelized phantom with color bar showing material indicies
tabulated in Tab. 7.1. (C.) Cylindrical regions of plaque were inserted at locations
within the gray and white matter of the slice. The diameter of the plaque regions
were 0.1, 0.4, and 0.6 mm.
Table 7.1 and Table 7.2 shows the tissue material present in the selected slices.
We obtained density estimates of the various tissues from the International Commis-
sion on Radiation Units & Measurements (ICRU) and the International Comission 1625
on Radiation Protection (ICRP). For a few materials, we supplied empirical x-ray
scattering measurements at small angles to accurately reflect the material’s molecu-
lar interference factors (MIF). For other materials, at the perimeter of the head, we
allowed simulations the theoretically calculate the independent atomic approxima-
tion (IAA) of x-ray scattering at small angles based on the elemental composition 1630
of the materials. The MIF more accurately reflects reality because it accounts for
the structure factor effects in SAXS.
Fig. 7.1 shows the Digimouse virtual phantom and the approximate location
of the coronal slice used for SAXS-CT simulations. We inserted regions of 0.1, 0.4,
and 0.6 mm diameter for neurological plaques. The MIF of the neurological plaques 1635






Figure 7.2: (A.) A representation of the MIDA virtual phantom and a line is drawn at
the approximate location of the transverse slice used for SAXS-CT simulations. (B.)
A transverse slice through the voxelized phantom with color bar showing material
indicies tabulated in Tab. 7.2. (C.) Cylindrical regions of plaque were inserted at
locations within the white matter of the slice. The diameter of the plaque regions
were 0.05, 0.2, 0.3, 0.4, 0.5, and 0.6 mm.
representation of the MIDA phantom with an approximate location of the transverse
slice used for SAXS-CT simulations. The size of the inserted neurological plaques
are 0.05, 0.2, 0.3, 0.4, 0.5, and 0.6 mm in diameter.
We simulated SAXS-CT with 0.1 mm translation steps for Digimouse and1640
0.05 mm translation steps for MIDA which were chosen because of the phantom’s
respective voxel size. We simulated 360 projections with 1 degree angular steps
around the phantom to reconstruct CT slice using filtered back projection. Since
Digimouse is a smaller phantom, we simulated runs with a monochromatic 16, 20,
and 33 keV x rays. 108 x-ray histories per translation position per projection to-1645
talling 5.6 × 1013 total x-ray trajectories simulated for a CT slice. The total time
for each set of SAXS-CT simulated on Digimouse phantom was approximately 2.5
hours. For MIDA phantom, we simulated at higher monochromatic x-ray energies
(60 and 70 keV) to account for the larger size (16-20cm). We also increased number
of histories simulated to 109 per translation position per projection totalling 1.7 ×1650
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Figure 7.3: (A and B.) Two whole slice fluorescent microscopy images of Tg mouse
brain with Thioflavin S dye using a 5x objective, 450 nm excitation, and 550 nm
emissions. (C.) A 20x zoom in on the bottom right corner of one Tg slices showing
amyloid deposits. (D.) 40x zoom of the red box region in C. showing approximate
size of the amyloid. (E.) The diameter of 420 amyloid plaques were manually mea-
sured using ImageJ software in 5 different Tg histological slices to provide a size
distribution.
1014 total x-ray trajectories simulated for a CT slice. The total time for each set of
SAXS-CT simulated on MIDA phantom was approximately 4.2 days.
7.3 Results
From our histological analysis, we learned that the mean diameter of the
plaques in our Tg mouse brains was 27.9±10.5 µm (±σ of 420 counted plaques). 1655
The amyloid load in the neocortex region of the brain was estimated to be 0.0013 de-
termined by the volume of plaques over the volume in the neocortex region. Fig. 7.3
shows two of the five histology slices imaged, an image of a few amyloids, and the
distribution of amyloid plaque sizes found in 5 slices studied.
Figs. 7.4 and 7.5 show photograph, histology, and PSAXS measurement com- 1660














Figure 7.4: (A.) Photograph of the 1 mm Tg brain slice measured. (B.) Fluorescent
microscopy image of the corresponding subsequent slice. Red dots are added to
improve visualization of the amyloid plaque locations. (C.) Intensity map at q at
0.22 nm−1. (D and E.) are intensity-based segmentation of C. (F.) Average scatter
profile of pixel regions from D and E. (G.) Intensity maps for the first 10 q bins.
a subsequent slice at 40 µm. Because of the small size of the plaques (28 µm in
diameter), we placed red dots to show locations where plaques were found. Using
a q intensity map at a small angle, intensity-based segmentation was performed to
find pixels with potential amyloid plaques on the basis that plaques are expected to1665
have higher intensities at lower angles. The pixels that had higher intensities at the
selected small-angle q appeared in the neocortex region of each of the slices. Fig. 7.4
shows region 1 also had a upward curve in intensities at small-angles compared to
the rest of the brain region.
Transgenic AD mouse model measurement results were compared to a wild-1670
type mouse brain measurement. We segmented the intensities in similar way at















Figure 7.5: (A.) Photograph of the 1 mm Tg brain slice measured. ( B.) Fluorescent
microscopy image of the corresponding subsequent slice. Red dots are added to
improve visualization of the amyloid plaque locations. (C.) Intensity map at q at
0.22 nm−1. (D and E.) are intensity-based segmentation of C. (F.) Average scatter
profiles of pixel regions from D and E. (G.) Intensity maps for the first 10 q bins.
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Figure 7.6: (A.) Photograph of the 1 mm WT brain slice measured. (B.) Intensity
map at q at 0.14 nm−1. (C and D.) are intensity-based segmentation of B. (E.)
Average scatter profile of pixel regions from C and D. ( F.) Intensity maps for the
first 10 q bins.
of the brain slice. The average scatter profiles from each region also showed a
similar profile, except for the higher intensity in region 1 which could be due to
higher density of myelin in the corpus callosum region. The expected upward turn1675
at small-angles was not apparent in this measurement as it were in the transgenic
AD brain measurements.
To assess the influence of instrument noise, we did a high resolution measure-
ment with 50 µm steps as opposed to 250 µm performed for other whole slice PSAXS
measurements. We selected the bottom left corner of another Tg brain slice. Each1680
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Figure 7.7: (Left) Photograph of measured brain slice with a red box indicating
region-of-interest. Histology of that location in a subsequent slice is shown below
the photograph. Middle and right columns show two repetition measurements of
the same region. Bottom shows the first 10 q bins of both sets of measurements.
was performed again and compared in Fig. 7.7. The second measurement set had
higher intensities than the first set, however the high intensity regions were con-
sistently in the same location shown at the bottom q bin images in Fig. 7.7. The
repetition experiment indicates longer exposure time is needed to remove effects of 1685
instrument noise as determined by differences in images from the two sets.
Fig. 7.8 shows a photograph of the measured brain slice. The BSA fibrils are
not visible in this image. However they are visible in the PSAXS images in Fig. 7.9
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Figure 7.8: Photograph of coronal slice of wild-type mouse brain acquired after
measurements. Location where BSA fibril pellet was placed is marked with red
circle.
which shows each q intensity map. The BSA fibrils are aggregates that have higher
intensities at low q angles therefore the first 10 images show the highest contrast of1690
the BSA fibrils compared to the rest of the brain tissue.
Using a intensity threshold approach, we segmented regions of BSA fibrils,
white matter, and gray matter. The BSA fibrils were segmented by the intensity
map at q of 0.21 nm−1 and thresholding above 21 cm−1 sr−1. The white matter and
gray matter were segmented by intensity map the first peak at a q of 0.95 nm−11695
and thresholding from 2 to 4 cm−1 sr−1 for white matter and 0.7 to 1.5 cm−1 sr−1
for gray matter. The results of these segmentated regions and their average scatter
profiles are presented in Fig. 7.10.
Fig. 7.11 and Fig. 7.12 shows the MC-GPU simulation results of SAXS-CT
on a slice of Digimouse and MIDA virtual phantoms with embedded regions of1700
neurological plaques of varying sizes. Fig. 7.11 shows that 16 keV for 1.5 cm thick



































Figure 7.10: (Left) Result of pixel segmentation based on intensity thresholds for
BSA fibrils, white matter, and gray matter. (Right) Average of scatter profiles for
pixels segmented with ±σ represented every 5 points.
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Table 7.3: Total Dose for 16, 20, and 33 keV SAXS-CT measurement of Digimouse
slice.
Energy (keV) Total Dose (Gy)
60 0.015
70 0.053
Table 7.4: Total Dose for 60 and 70 keV SAXS-CT measurement of MIDA slice.
shows undersampling artifacts in the reconstructed CT images at various angles.
Artifacts are reduced in the measurement set at 20 keV and further reduced in
measurements with 33 keV. In the measurement set with 33 keV x rays, even the1705
smallest plaque at 0.1 mm is visible in the white matter at small-angles.
Simulation results shown in Fig. 7.12 for the MIDA human head slice show
neurological plaques down to 0.3 mm in diameter. Because the human head is
much thicker at approximately 16-20 cm, higher energy x rays are needed to escape
the tissue. However, a larger proportion of x rays at high energies will also be1710
transmitted with no interaction with the tissue, therefore we simulated these sets
with 10 times the number of x rays to improve signal.
Table 7.3 presents the estimated total dose deposited on the Digimouse head
for SAXS-CT measurements. Likewise, table 7.4 shows the total dose deposited to
the MIDA head. We had calculated less dose deposited on the MIDA head than the1715
Digimouse head due to the higher energy of the x rays used even though more total





Figure 7.11: SAXS-CT simulation results using MC-GPU on Digimouse slice. First
column is a slice through voxel phantom. The second column is the attenuation
image. The 3rd to 6th images are intensity maps reconstructed from a specific q
angle indicated below the image. First row shows results of simulations with 16 keV
x rays, second row shows simulations with 20 keV, and last row shows simulations
performed with 33 keV.
q (nm-1)
Slice Att 0.10586 0.70573 1.4114 2.8228
q (nm-1)
Slice Att 0.10511 0.70072 1.4014 2.8028
60	  keV	  
70	  keV	  
Figure 7.12: SAXS-CT simulation results using MC-GPU on MIDA slice. First
column is a slice through voxel phantom. The second column is the attenuation
image. The 3rd to 6th images are intensity maps reconstructed from a specific q
angle indicated below the image. First row shows results of simulations with 60 keV
x rays, bottom row shows simulations performed with 70 keV x rays.
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7.4 Discussion
In this work, we have performed histological analysis of the amyloid load on
Tg mouse brain, measured PSAXS of a few Tg slices, compared results to a WT1720
mouse brain, demonstrated SAXS imaging differentiation of amyloid fibril model on
a WT mouse brain, and simulated SAXS-CT on a mouse head and human head
with embedded amyloid plaques to demonstrate feasibility.
Through our histological work, we found the plaque sizes to be smaller than
the resolution of our PSAXS measurements with a mean diameter of 28 µm. While1725
it is possible to measure at 10 µm resolution step sizes and beam size at modern
synchrotron sources, our system is limited to a 200 µm beam size. While we may
not be able to measure single neurological plaques with our system, we postulated
that if a plaque was within the beam, that there would be increased intensities at
small-angles due to the scattering contribution from the plaque or plaques. Because1730
the size of the plaques, we cannot use the subsequent slices that were analyzed with
histology for a registration map of these plaques, however, we are able to estimate
regions where amyloid exist.
Our measurements of the Tg slices show that pixel locations with high intensi-
ties at small-angles are present in regions of the neocortex where plaques are shown1735
to exist in histology. As expected, these pixels showed scatter profiles with increased
intensities below 0.5 nm−1. We performed the same intensity-based segmentation
at small angles on a region of a WT mouse brain and found that the scatter profile
of more intense pixel regions did not show the same characteristic upward turn at
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small-angles as the Tg brain intense pixels. 1740
In addition, we performed a higher step resolution of 50 µm with a 200 µm
beam size in a particular region-of-interest in a transgenic brain twice to rule out
intense pixel regions due to system noise. While results from the two measurements
were not identical, the centers of intense pixel regions were consistent between the
two measurements. Differences could be attributed to the long period of time re- 1745
quired for measurements. Each set took approximately a week, therefore the same
brain slice was in the system for 2 weeks and could have experienced more degra-
dation and drying during measurements. With a known amyloid target at a known
location, a signal-to-noise estimate can be ascertained.
We have demonstrated that SAXS imaging can be used to differentiate amy- 1750
loid fibrils from normal tissue by their small-angle scatter profile characteristics.
Aggregation tends to curve upwards at low q angles and this characteristic can be
utilized in SAXS imaging to locate and track growth of brain plaques in vivo with-
out the use of any contrast agents or molecular tags. We demonstrate this with a
model amyloid system of BSA fibrils where the amyloid target could be placed at a 1755
known location and with a known size.
The BSA fibril pellet was mostly translucent and after placing on the brain
slice, it was difficult to locate. The BSA fibrils are not visible in the photograph in
Fig. 7.8 but are clearly visible in the SAXS images shown in Fig. 7.9.
A corpus callosum structure is apparent in the 5th row and again in the 8th 1760
row in Fig. 7.9. This is due to the highly scattering myelin structure that is most
dense in the corpus callosum. The images in these rows correspond to the two peaks
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in the scattering profile in Fig. 7.10 at q of 0.95 and 1.6 nm−1. The gray matter
region also have these peaks but they are more diffuse. They are also apparent in
the BSA fibril average signal since the fibrils were superimposed on brain tissue.1765
A large contributor to our success in detecting amyloid fibrils was the density of
the fibrils measured since density affects intensity scale in scatter profiles. The den-
sity of BSA amyloid fibrils was estimated to be approximately 31.5 mg/cm3 and the
approximate amyloid load was calculated to be 0.0997 which is within normal range
of amyloid plaque in Tg mice 12 to 70 weeks old. [67] This was much higher than the1770
calculated amyloid load of the Tg brains that we had which were 0.0013. PSAXS
signal quality is affected by sample thickness and therefore applications are limited
to ex vivo biopsy studies. However, SAXS computed tomography (SAXS-CT) uses
image reconstruction algorithms to obtain SAXS profiles of locations deep within
objects enabling applications in in vivo molecular x-ray imaging. This technique1775
has been demonstrated study biological tissues and plastics. [39, 46, 47, 52, 75, 91]
Simulations of the Digimouse head show that 33 keV x rays achieve increased signal
and minimize dose over 16 and 20 keV x rays. The MIDA phantom simulation show
a minor improvement in signal quality in the 70 keV x-ray simulation over the 60
keV x-ray simulation determined by ability to see the 0.3 mm diameter embedded1780
plaque. The 0.2 mm and 0.1 mm plaque sizes were not visible in these images.
Higher energy x rays and larger number of x rays are needed for SAXS-CT imaging
of a human head. The optimal energy that balances signal and dose have yet to
be determined for a mouse and human. However, we have determined that it is




We demonstrate feasibility of SAXS imaging of amyloid. Transgenic Alzheimer’s
disease (AD) mouse brains and a wild-type mouse brain were measured using pla-
nar SAXS and compared. Amyloid plaques were found to have higher intensities 1790
at small angles and intensity maps at q bins below 0.5 nm−1 is the range that was
investigated for detection of amyloid targets. However, amyloid plaque detection in
our SAXS system is limited by amyloid size and density. Histological analysis of
40 µm thick subsequent slices to 1 mm slices we imaged using planar SAXS showed
the distribution of plaque sizes centered around 28 µm in diameter with a σ of 1795
±10 µm from 420 plaques counted in transgenic AD mouse brains. The plaques
also appeared more frequently in the neocortical region of the brain slices. Our
SAXS system spatial resolution was limited by the beamsize which was 200 µm in
diameter and was not well-suited for detection of individual plaques in transgenic
AD mice. A SAXS system with beamsizes and scanning step sizes ≤10 nm would 1800
be better suited for detection of individual amyloid plaques in transgenic AD mice.
In spite of our SAXS system spatial resolution limitation, we have found higher
intensity pixels in intensity maps at q bins below 0.5 nm−1 in the neocortex region
where plaques are known appear in higher frequency. The x-ray scattering contri-
bution from a single or multiple plaques within the SAXS beam assisted in a coarse 1805
detection of plaques. To further demonstrate feasibility of amyloid detection, we
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utilized an amyloid fibril model from bovine serum albumin with 0.8 mm diameter
and placed it at a known location on a wild-type mouse brain slice and we were able
to spatially locate the plaque. The estimated amyloid load of this fabricated AD
model was 0.0997 which is within normal range of amyloid plaque in Tg mice 121810
to 70 weeks old. Finally, we performed x-ray transport simulations of SAXS-CT of
a virtual mouse model head (Digimouse) and a virtual human head (MIDA). The
simulations performed on Digimouse showed that for a mouse head approximately
1-2 cm in diameter, 33 keV x rays were optimal for detection of plaques down to
0.1 mm in diameter. 33 keV x rays also had the least amount of radiation dose de-1815
posited (4.42 Gy) to the head compared to measurements with 16 (6.08 Gy) and 20
keV (6.42 Gy). Simulations performed on the MIDA human head phantom, showed
that with 70 keV x rays, the minimum detectable plaque size was 0.3 mm diameter,
and with 60 keV x rays, the minimum detectable plaque size was 0.4 mm diameter.
However, SAXS-CT simulations using 60 keV had 15 mGy dose deposited whereas1820
simulations using 70 keV had 53 mGy. Also, higher energy x rays for human head
applications also required higher number of total x rays simulated to obtain enough
scattering signal to distinguish plaque regions because a larger proportion of the x
rays transmit without interaction. Further simulations are needed to fine tune opti-
mal x-ray energies for small animal and SAXS-CT human head imaging for amyloid1825
plaques. However, the outlook of utilizing SAXS-CT imaging for in vivo detection
of amyloid plaque is promising. We have demonstrated simulations could be used to
design dedicated SAXS-CT systems for small-animal and human amyloid imaging
applications.
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Chapter 8: Future Work 1830
Small-angle x-ray scattering techniques for medical imaging have been ad-
vanced by the work presented in this dissertation. We initially explored biomarkers
in vitro and observed aggregation growth of β amyloid and tau two time points of
SAXS measurements. We developed a method of incorporating experimentally mea-
sured cross sections into a GPU-accelerated Monte Carlo simulation tool of x-ray 1835
transport to improve realism at small-angles and study optimal energy and thickness
for a potential in vivo application of SAXS imaging. We also proposed a method
to study depth limit of SAXS-CT systems. A comprehensive study on SAXS and
XRD studies of mouse brain were reviewed and compared to our own results of
PSAXS measurements. We imaged planar SAXS of transgenic Alzheimer’s disease 1840
mouse model brains and compared them to histology and wild-type measurements.
We were successfully able to image and locate an amyloid fibril model constructed
from BSA on a wild-type mouse brain slice. Finally, simulations of SAXS-CT of
mouse and human head with embedded neurological plaques were performed and
results demonstrated theoretical feasibility to image amyloid plaques in vivo with 1845
optimized instrument settings.
Because amyloid plaques are aggregates of β amyloid, small-angle x-ray scat-
122
tering is the appropriate angular range to look for differentiating cross section be-
tween that and of regular tissue. We found that amyloid scatter profiles in the brain
curved upwards at q ≥ 0.5 nm−1. The upward turn at q ≥ 0.5 nm−1 characteristic of1850
amyloid plaque could serve as a biomarker for Alzheimer’s disease in vivo. Simula-
tions of SAXS-CT system using 33 keV x rays allowed for detection of neurological
plaques down to 0.1 mm diameter within a virtual mouse head with a CT slice size
of 1.5x1.5 cm2 and the estimated radiation dose deposited on the mouse head for
one slice was 4.42 Gy. 16 and 20 keV energies were also probed for mouse head1855
SAXS-CT imaging applications, however, simulations using 33 keV x rays produced
the least amount of undersampling artifacts for the same number of x rays simu-
lated (1013 x rays) and also produced the least amount of dose deposited. We also
performed simulations of SAXS-CT with 60 and 70 keV x rays on a virtual human
head between 16-20 cm in diameter. We simulated 10 times the number of x rays1860
for the virtual human head to increase the amount of x rays reaching the detector.
0.4 and 0.3 mm diameter plaques were detected with an estimated radiation dose
of 0.015 and 0.053 Gy in SAXS-CT simulations with 60 and 70 keV respectively.
Smaller plaques could theoretically be detected with more simulated x-rays histo-
ries. Simulations of a mouse head and human head reveal that SAXS-CT could be1865
used to image amyloid plaques in vivo. Further work is needed to more finely assess
optimal x-ray energies to use for small-animal and human heads for detection of
plaques between 10 to 50 µm in diameter. From our initial work we have found 33
keV optimal for mouse head and between 60 to 70 keV for a human head.
There are still key challenges that need to be addressed for SAXS-CT to be1870
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a practical tool for in vivo amyloid imaging. The dose to the sample should be
minimized and measurement times need to be reduced. The current upper limit
for clinical head CT for humans is 60-80 mGy. [58] Our simulations of SAXS-CT
with 60 keV x rays deposited only 15 mGy in the human head and we were able to
detect plaques of size 0.3 mm in diameter. Through histological analysis, we found 1875
the size of amyloid plaques in transgenic AD mice were about 10 times smaller at
approximately 0.03 mm in diameter and amyloid plaques are reported to be a similar
size in humans. [78] Step sizes and smaller beams below 10 µm are necessary for
the detection of individual plaques. Synchrotron sources can already achieve a 10
µm2 beamsize using x-ray microfocusing instrumentation. In addition, synchrotron 1880
SAXS sources have x-ray flux of 108 x rays/s/µm2 as opposed to laboratory SAXS
sources with x-ray flux of approximately 102 x rays/s/µm2. Given the flux and
beam size specification of synchrotron sources, individual amyloid plaque imaging
using SAXS-CT may be feasible at measurement times in the order of a few minutes
to a few hours depending on the step resolution and number of projections used. 1885
However, laboratory SAXS-CT system for amyloid imaging at present requires days.
For practical use in clinics and for in vivo amyloid imaging, measurement times need
to be reduced in SAXS-CT systems. One approach to shorten measurement times
in laboratory systems is the use of liquid metal jet sources which allow flexibility
in x-ray spectra and higher flux. In addition, the use of 2D spectroscopic x-ray 1890
detectors eliminate the need to filter x rays for monochromation and allow for more
efficient usage of x rays generated. The entire spectra of x rays generated could
be collected and each energy bin could be used to calculate a different scattering
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angle. With energy bins below 1 keV, the wavelength effect of smearing on the
scatter profile becomes negligible. Furthermore, measurement times can be reduced1895
by locally imaging a smaller region-of-interest.
In another approach, SAXS imaging could be used more coarsely to assess
amyloid load by the contribution of x-ray scattering from multiple plaques illumi-
nated within a larger beam (0.1-1 mm2). Shorter measurement times are achieved
by lower resolution scanning and larger beamsizes. Denser plaque regions would1900
contribute more to higher intensities below 0.5 nm−1. We have planar SAXS im-
aged transgenic AD mouse brains slices with 0.2 mm2 beam. Higher intensities are
present in intensity maps at 0.22 nm−1 in the neocortical regions where histology
of subsequent slices show plaques to be present. More work is needed to correlate
intensity of these regions to amyloid load, a metric commonly used clinically to as-1905
sess progression of Alzheimer’s disease. Theoretically, the measured scatter profile
is a linear combination of individual material scatter profiles. A least-squares ap-
proximation of measured scatter profiles with basis functions formed by known cross
sections of amyloid plaques and brain tissues could be used to estimate amyloid load
in any pixel in a SAXS-CT image.1910
The outlook of SAXS imaging for applications in medical imaging is promis-
ing for assessing pathology by structural tissue differentiation between normal and
diseased states. As a result of the work performed during this PhD program, knowl-
edge in the field of SAXS imaging for medical applications has been advanced and
evidence of feasibility for SAXS-CT imaging for detection of amyloid plaques is1915
stronger. Optimization of maximized signal and minimized dose for small animals
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and humans could be addressed in silico using MC-GPU simulations along with
the design of dedicated SAXS-CT systems for amyloid detection. We also plan
to develop a hybrid energy-dispersive, angular-dispersive SAXS-CT system using a
2D spectroscopic x-ray detector to collect all generated x-rays and assess improve- 1920
ments in measurement times. Concurrently, we plan to also use planar SAXS to
further study correlation of scattering intensities below 0.5 nm−1 to amyloid load in
brain tissues of transgenic and wild-type mice. Techniques to assess image quality
quantitatively will be developed and implemented.
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